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Human Holocarboxylase Synthetase (HCS) transfers the vitamin biotin to the 
biotin carboxyl carrier protein (BCCP) domains of five biotin-dependent 
carboxylases. There are two major forms of HCS present in mammalian cells, which 
differ by 57 amino acids at their N-terminus. Both variants catalyze biotinylation 
through a two step reaction in which an activated intermediate, bio-5‟-AMP, is first 
synthesized from biotin and ATP. In the second step, the biotin moiety is covalently 
attached to a specific lysine residue on the carboxylase. The mammalian carboxylases 
comprise the cytosolic acetyl-CoA carboxylase 1 (ACC1), the outer mitochondrial 
membrane bound acetyl-CoA carboxylase 2 (ACC2), and the three mitochondrial 
carboxylases pyruvate carboxylase (PC), 3-methylcrotonyl-CoA carboxylase (MCC) 
and propionyl-CoA carboxylase (PCC).  
 
In order to investigate the HCS reaction mechanism and specificity, both 
isoforms were recombinantly expressed, purified, and biochemically characterized. 
The basic mechanistic features of the two HCS variants were investigated using 
steady state and pre-steady state kinetic methods. The latter methods allow the 
determination of the rates of bio-5‟-AMP synthesis and biotin transfer independent of 
each other. Both isoforms catalyze the overall reaction similarly and synthesize bio-
5‟-AMP with a rate of 0.1s
-1
. Biotin transfer to the BCCP domain fragments of ACC1 
and ACC2 carboxylases, to which HCS has continuous access from the cytosol, is 
slow and saturable. In contrast, biotin transfer to the BCCP domain fragments from 
the mitochondrial carboxylases PC, PCC and MCC is characterized by rates that are 
significantly faster and limited by the collision of enzyme and acceptor substrate. The 
same pre-steady state methods were applied to two biotin ligases from archaea and 
prokarya, and showed that this collision limited biotin transfer mechanism is 
widespread among evolutionary domains.  
The observation of a collision limited reaction emphasizes the role of protein 
substrate recognition in the biotinylation reaction, and provides a mechanism for 
establishing a hierarchy among carboxylases that favors mitochondrial substrates. 
This default hierarchy can be overridden according to cellular demands by modifying 
the carboxylases‟ expression. The results support the idea that in the cell one of the 
mechanisms of biotin-related metabolism regulation relies on HCS specificity to 
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Chapter 1: Background and introduction 
 
1.1 Introduction 
Cells adjust the flux of their metabolic processes in a constant effort to 
maintain homeostasis. This is a natural response to stress that aids in cell survival and 
adaptability. Central to this response is the ability to control and regulate processes 
such as enzymatic activity, transcription and translation as a function of nutritional 
needs. This work lays the foundation to understand the biochemical basis of those 
processes that determine the metabolic fate of the nutrient biotin in mammalian cells. 
In particular, it focuses on expanding our understanding of human holocarboxylase 
synthetase (HCS), a key enzyme in biotin related metabolism and regulation. 
1.1.1 Biotin 
Biotin, also known as vitamin B7 or vitamin H, is an essential nutrient 
required by most organisms for viability. The only organisms that do not require 
biotin are the Lyme disease causing agent Borrelia burgdorferi, the endocellular 
symbiont Buchnera sp., mycoplasmas and thermoplasmas (1). Most prokaryotes, 
plants and some fungi can synthesize biotin (2). In contrast, most higher eukaryotes, 
including all animals, depend on their diet as a source of the vitamin. Alternatively, it 
is been suggested that the bacterial community of the intestinal flora may also 
function as a biotin source for higher organisms (3). 
Biotin was originally discovered by Margaret Boas in 1927 when she 
recognized that there was a component in certain foods that protected mice against 
„egg white injury‟ (4). She named this component „protective factor X‟. Today, the 
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„egg white injury‟, a condition characterized by severe dermatitis, loss of hair, and 
lack of muscular coordination, is known to arise from the presence of the protein 
avidin in the egg white (Fig. 1A). Avidin, which binds biotin with one of the tightest 
binding affinities known to date, prevents biotin absorption by the mice. In 1940, Paul 
Gyorgy realized that the vitamin H that he had extracted from liver in 1931, as well as 
the coenzyme R from Rhizobium discovered by Allison in 1933, and the biotin 
isolated from egg yolk by Kogl and Tonnis in 1935, were all one and the same (5).  
Subsequently, the structure of biotin was solved by DU Vigneaud in 1942 (6), after 
recognition that biotin is composed of a ureido ring fused with a tetrahydrothiophene 
ring and a carboxyl group on an n-valeric acid side chain (Fig. 1B). Only one of the 




Figure 1. Biotin and the egg white injury. A. Picture of a mouse displaying egg white 
injury. The symptoms are observed after depriving mice from biotin by feeding them 






1.1.2 Biotin as a cofactor 
The importance of biotin derives from its function as a cofactor for biotin-
dependent carboxylases. In the carboxylation reaction, a carboxyl group is added to 
one molecule, for example, acetyl-CoA, to produce another metabolite that has been 
extended by one carboxyl group, like malonyl-CoA. Biotin acts as an intermediate 
carrier of the carboxyl group, which is originally taken up from a bicarbonate donor 
and eventually handed to the metabolic acceptor molecule (Fig. 2A). The reaction is 
complex, and is catalyzed in distinct spacio-temporal steps that occur in different 
carboxylase domains ((8), Fig. 2B). Biotin performs its carrier function while 
covalently attached to a specific lysine of the BCCP (biotin carboxyl carrier protein) 
domain. This domain works as a swinging arm, able to reach TC and BC domains 
more than 60Å away (9). The BCCP domain interacts first with the BC domain 
(biotin carboxylase), where ATP is used to activate bicarbonate by producing a 
carboxyphosphate intermediate. This reaction also requires divalent ions. After the N-
1 position of biotin is carboxylated, the BCCP domain brings the biotin to the TC 
(transcarboxylase) domain, where the carboxyl group is indirectly transferred to the 













Figure 2. Biotin dependent carboxylases reaction and domain structure. A. The 
carboxylase reaction involves taking bicarbonate and ATP to transiently transfer a 
carboxyl group to biotin. The carboxyl group is subsequently added to either 
pyruvate, acetyl-CoA, propionyl-CoA or methycrotonyl-CoA, depending on the 
identity of the carboxylase(8,11). B. Carboxylases are composed of repeating units of 
the BC, BCCP and CT domain. The flexible linker (green) of the BCCP domain (red) 
moves the biotin moiety between the BC (blue) and TC domain (gold), where the two 








1.1.3 Biotin dependent carboxylases 
Biotin dependent carboxylases are involved in a variety of metabolic 
processes, some of which are essential for cell viability. Most organisms, as is the 
case in the widely studied E. coli, possess at least one such carboxylase, namely 
acetyl-CoA carboxylase (ACC). This carboxylase catalyzes the conversion of acetyl-
CoA to malonyl-CoA, and as a result, is of fundamental importance for fatty acid 
anabolism. Indeed, this chemical step is the first committed step of fatty acid 
synthesis. In E. coli, the enzyme consists of four polypeptides, BC, BCCP, TC- and 
TC- (12).  However, the overall stoichiometry of subunits is still a matter of debate.  
Mammalian cells have five biotin dependent carboxylases involved in various 
metabolic processes (Fig. 3A,B). Like the bacterial ACC, cytosolic acetyl-CoA 
carboxylase 1 (ACC1) is involved in fatty acid synthesis by catalyzing the conversion 
of acetyl-CoA to malonyl-CoA. Because this carboxylase has been linked to obesity 
and diabetes, it has been the topic of much research.  The BC, BCCP and TC domains 
of the mammalian enzyme lie on a single polypeptide whose regulation has been 
found to be multi-level and complex. The expression pattern varies depending on the 
tissue, with the highest levels occurring in adipose tissue (13). In addition, the mRNA 
can be alternatively spliced to produce different variants. The expression levels are 
responsive to glucose, insulin, thyroid hormone and leptin (14). Citrate and glutamate 
are among the currently identified allosteric regulators of ACC1, and citrate is known 
to activate ACC1 by inducing homopolymerization of the enzyme (15). ACC1 
activity can be inhibited by hormone responsive phosphorylation of several residues. 
This extensive regulation at multiple levels and the fact that an ACC1 knock-out 
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Figure 3. Mammalian biotin dependent carboxylases associated metabolic pathways 
and assembly states. A. Mammalian cells have five different biotin dependent 
carboxylases that are involved in a variety of metabolic pathways. B. Mammalian 
biotin dependent carboxylases are large multimeric complexes. The domain 
architecture is highlighted by the different colors. The number of times that the 
domains are repeated in an active complex is shown on the right.  Biotin is attached to 





Acetyl-CoA carboxylase 2 (ACC2) is the product of a different gene than that 
coding for ACC1, although the two enzymes maintain 70% similarity (11). It 
catalyzes the same reaction as ACC1, but is involved in regulation of fatty acid 
oxidation. Even though the two ACCs catalyze the same reaction the two are not 
interchangeable and have different functions. This is evidenced by the very different 
results obtained with ACC2 mice knockouts, which aside from a few phenotypic 
traits, mature normally (17).  A publication by Soo Choi et al. indicating that the 
ACC2 knockout mice displayed increased insulin sensitivity and continuous fat 
oxidation led to much interest to use this enzyme as a target to treat diabetes and 
obesity (18). However, a more recent paper suggests that the phenotypes are not as 
pronounced as originally thought (17). An N-terminal leader sequence is responsible 
for its localization and anchoring to the cytoplasmic side of the outer mitochondrial 
membrane (19). ACC2 displays differential tissue expression, with increased 
expression in muscle, and there are also different splice variants (14). It also contains 
several phosphorylation sites that may be involved in its regulation (14). Therefore, 
ACC2 is also subject to extensive regulation.  
Propionyl-CoA carboxylase (PCC) catalyzes the conversion of propionyl-CoA 
to S-methylmalonyl-CoA. It is part of the odd-chain fatty acid synthesis pathway and 
is also involved in isoleucine, threonine, methionine and valine catabolism. The 
enzyme localizes to the mitochondrial matrix. It is a 66 heterododecamer, with the 
alpha subunit carrying the biotin moiety (11). PCC has also been established as an 
essential gene product, since knock-out mice die hours after birth (20).  
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Pyruvate carboxylase (PC) carboxylates pyruvate to produce oxaloacetate. 
The enzyme is a mitochondrial homotetramer involved in gluconeogenesis and fatty 
acid synthesis. There are at least two mRNAs that arise from differential splicing of 
the 5‟UTR. These variants have different tissue-dependent expression resulting from 
the control of two different promoters (21).  In rats, the expression from these 
promoters display different transcriptional response to hormones and metabolites 
induced upon fasting or by diabetes. PC is allosterically activated by acetyl-CoA, but 
no phosphorylation-dependent regulation has been identified.  
Methycrotonoyl-CoA carboxylase (MCC) converts 3-methylcrotonoyl-CoA to 
3-methylglutaconyl-CoA. It is a heterododecameric mitochondrial enzyme involved 
in the degradation of the amino acid leucine. Its oligomeric structure is of the ()6 
form, and the biotin is attached to the alpha subunit. The enzyme is mainly expressed 
in kidney and liver tissue. It has been reported that, in plants, a mechanism for 
regulating its activity among different plant organs is based on the extent of 
biotinylation (22). 
1.1.4  Biotin protein ligases 
Biotin protein ligases (BPLs) catalyze attachment of biotin to the specific 
lysine on the carboxylases BCCP domain, and understanding this class of enzymes 
has been the main focus of our efforts. The biotin transfer reaction occurs in two 
steps. In the first step an activated intermediate, bio-5‟-AMP, is synthesized from 
biotin and ATP, with the release of pyrophosphate. This occurs through the formation 
of an anhydride bond between the biotin carboxyl group and the ATP alpha 
phosphate (23). The second step involves covalent attachment of the biotin moiety to 
 9 
 
a carboxylase acceptor lysine residue. The products of this second half reaction are 





Figure 4. Biotin protein ligase reaction. The reaction occurs in two steps. First, an 
activated bio-5‟-AMP intermediate is formed from biotin and ATP. Then, the biotin 
moiety is transferred to a specific lysine on the BCCP domain of carboxylases, with 
the release of AMP as a product. 
 
 
1.1.5 BirA  and other ligases 
The majority of the knowledge on ligases originates from studies performed 
with the E. coli enzyme, which is also known as BirA. This protein is a 35kDa 
metabolic enzyme and transcriptional repressor. Its N-terminal domain contains a 
DNA binding motif, while the C-teminus contains the catalytic residues involved in 
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bio-5‟-AMP synthesis and biotin transfer (24). BirA is central to the sensing and 
maintenance of biotin homeostasis in E. coli, by virtue of its ability to function as a 
repressor and a biotin ligase (25).  After bio-5‟-AMP synthesis, BirA can either 
transfer biotin to the BCCP domain of ACC, or it can homodimerize (Fig. 5). BirA 
dimers can act as transcriptional repressors by directly binding to a DNA regulatory 
sequence and inhibiting the expression of the biotin biosynthetic operon (26). As a 
result, BirA function will depend on biotin concentration and levels of unbiotinylated 
BCCP (27). When the concentration of biotinylated carboxylase is high, BirA will 
homodimerize and bind to the operator. On the other hand, when most of the 
carboxylases are unbiotinylated, BirA will heterodimerize with the carboxylase and 
biotinylate the BCCP subunits. Because the dimerization reactions utilize the same 
surface on BirA, they are mutually exclusive, and their dominance will determine if 
biotin is channeled towards metabolism or transcriptional repression. Mechanistically, 
hetero- and homo- dimerization events are isoenergetic, and this switch is kinetically 
controlled. Since heterodimerization is much faster than homodimerization, 
transcriptional repression will occur only after the pool of unbiotinylated BCCPs has 
been exhausted (28-29). BirA is, therefore, the key species through which biotin is 









Figure 5. The biotin regulatory switch of E. coli (30). Apo-BirA binds ATP and biotin 
to produce bio-5‟AMP and form holo-BirA. Partitioning of holo-BirA function 
between metabolic activator and transcriptional repressor occurs through competition 
of hetero- and homo-dimerization. If BirA transiently heterodimerizes with a 
carboxylase, it will transfer the biotin moiety to the carboxylase BCCP domain, and 
activate metabolism. However, if holo-BirA homodimerizes it is now able to bind a 
specific sequence upstream of the biotin biosynthetic operon and repress expression. 
 
 
 Not all lower organism ligases are bi-functional (1). Monofunctional ligases 
catalyze biotin transfer to carboxylases, but do not regulate transcription in response 
to the vitamin. The monofunctional ligases characterized to date can be monomeric or 
constitutive dimers (31-33). Of particular interest has been the ligase from the 
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Pyrococcus horikoshii archeon due to the availability of crystal structures of a mutant 
enzyme bound to the BCCP fragment (34). It is noteworthy that this ligase does not 
homodimerize with the same surface that BirA uses, but both ligases use the same 
area to interact with BCCP. Several key residues were identified in the structure, 
many of which had been previously probed in BirA by alanine replacement. In 
addition, a large number of backbone contacts were identified. These backbone 
interactions are thought to be responsible for the ability of ligases to biotinylate 
BCCP from other species. 
1.1.6 The mammalian biotin protein ligase, or human holocarboxylase 
synthetase 
In contrast to the E. coli system, the mammalian biotin regulatory network is 
not as well understood. A link between biotin and transcriptional status of several 
genes has been known since the 1960s. However, the mechanism by which biotin 
affects transcription remains elusive.  Studies in mammalian fibroblasts with mutant 
biotin ligase indicate that these cells are defective in biotin-responsive transcriptional 
response and suggest that the human ligase, like its E. coli counterpart, plays a role in 
biotin regulation (35). It has been proposed that the mechanism might involve direct 
biotinylation of nucleosomes (36), but the inability to detect endogenous biotinylated 
histones with methods other than antibodies has raised doubts about this hypothesis 
(37). Alternatively, a lack of biotin-transcriptional response in normal HepG2 upon 
inhibition of soluble guanylate cyclase suggested that regulation might occur through 
a signaling cascade involving the biotin ligase and PKG. 
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The human biotin ligase or human holocarboxylase synthetase (HCS or 
HsBPL), is a 726 amino acid protein with a molecular weight of 81 kDa. The C-
terminal domain encompasses the catalytic region and is 36% identical to BirA across 
a 126 amino acid region, while its N-terminal sequence bears no homology to any 
known protein except to the N-terminus of other higher organism ligases (38).  
Characterization of HCS mRNA indicated that of the many different spliced mRNAs, 
two code for proteins differing on the N-terminus (39). One variant is the full-length 
protein and the other is a 74 kDa form, 58-HCS, which lacks the first 57 amino acids 
at the N-terminus. An additional intermediate, 7-HCS, which lacks the first 6 amino 
acids, has been proposed to arise from skipping of the first initiation codon in the full 








Figure 6. HCS isoforms. There are two main isoforms of HCS in human cells, FL-
HCS and 58-HCS. The sequence of the additional 57 N-terminal residues that 
distinguishes between full length HCS and 58-HCS, the two isoforms found in 





The HCS N-terminus appears to be involved in biotin acceptor substrate 
recognition. Studies that examined biotinylation of a truncated form of the BCCP 
domain of the mammalian PCC and of the bacterial BCCP substrate by different 
truncations of HCS in E. coli cell extracts determined that enzymes containing 
intermediate length N-terminal deletions interfered with biotin acceptor substrate 
recognition(41).  In NMR studies performed with the BCCP domain of ACC2 and an 
N-terminal fragment of HCS consisting of residues 1-160, Lee et al. showed that the 
N-terminal domain affects the chemical shift of several residues of ACC2 BCCP (42). 
In addition, biotinylating activity was observed when adding the N-terminal HCS 
fragment and 160-HCS in trans, but it was compromised when catalyzed by the 160-
HCS fragment alone. 
Localization of HCS has been a matter of some debate. HCS displays no 
viable mitochondrial or nuclear localization signal (38). Narang et al found that HCS 
localized primarily to the nucleus (43). However, subsequent experiments with GFP-
tagged HCS, as well as western blots, determined that FL-HCS localizes primarily to 
the cytoplasm (44). The same study determined that the majority of 58-HCS is also 
found in the cytoplasm, while a small fraction is present in the nucleus.  Western blot 
analysis of isolated mitochondria was inconclusive regarding the presence or absence 
of HCS in this organelle. A different study of fresh placenta tissue by western blot 
showed that HCS was mainly in the cytoplasm. The mitochondrial fraction showed a 
band at 62 kDA that was proposed to be an isoform specific to the mitochondria (40). 
A few studies have addressed the regulation of HCS. It was proposed that 
HCS was transcriptionally regulated as a function of biotin (35,45), but mRNA levels 
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of HCS do not always change with biotin concentration (46). Differential localization 
of the various isoforms in response to biotin is a plausible regulatory mechanism of 
carboxylase biotinylation. However, studies to determine the identity of the 62 kDa 
band observed in the mitochondria, and to assess distribution of HCS as a function of 
biotin have not been performed. In addition, a possible mechanism for regulation at 
the protein level emerged when a proteomic study identified threonine 146 and serine 
147 as two likely phosphorylation sites on HCS (47). This finding, taken together 
with the activation of guanylate cyclase by biotin (48), raises the possibility that 
protein kinase G (PKG) is activated to phosphorylate transcription factors and, 
perhaps, HCS. The relevance of phosphorylation for HCS activity is also unknown, as 
are the kinases involved, but they suggest an additional level of regulation of biotin 
metabolism. 
1.1.7 Biotin protein ligase-BCCP interaction 
Although there are studies that provide information on structural and sequence 
elements important for BCCP recognition, a thorough understanding is still lacking. 
The crystal structure of the thermophillic Pyrococcus horikoshii ligase bound to the 
BCCP fragment is available(34). The ligase-BCCP interface is characterized by 
hydrogen bonds among backbone residues and extensive van der Waals contacts. 
However, not many of the interacting residues appear to be mediating specific 
contacts likely to be responsible for the protein-protein recognition specificity. In 
addition, screens have yielded peptides with amino acid sequences that do not 
resemble BCCP but can be biotinylated as efficiently, further highlighting the 
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challenge in the determination of the sequence/structural elements responsible for 
specificity(49).   
The importance of several residues for the BCCP-ligase interaction has been 
obtained through mutational studies on both proteins. Studies on E. coli BCCP have 
identified, in addition to the target lysine, a glutamic acid at position 119 and several 
conserved glycine residues that affect biotinylation(50). Unexpectedly, mutation of 
the highly conserved methionine residues surrounding the target lysine in the MKM 
motif does not significantly affect biotinylation(51). In the E. coli ligase several 
surface loops are proposed to function in BCCP recognition and mutational analysis 
of these loops has identified R116 and R119 as important for interaction with 
BCCP(52). These residues are found in one of the conserved BirA loops, and are 
therefore likely to be important for the recognition of BCCP by ligases from all 
organisms. 
1.1.8 Multiple carboxylase deficiency 
Mutations on the HCS gene can lead to Multiple Carboxylase Deficiency 
(MCD), a disease characterized by ketoacidosis, organic aciduria and mental 
retardation (53-54). MCD presents a combination of the symptoms associated with 
deficiency of the individual carboxylases. There are no known naturally occurring 
HCS mutants that do not have at least some residual biotinylating activity, and null 
mutations are thought to be lethal in accord with HCS importance in biotin 
metabolism. MCD makes characterization of HCS and the effect of mutations even 
more pressing, although most MCD cases can be managed with pharmacological 
doses of biotin.  
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Information regarding the effect of certain amino acid changes on HCS 
activity can be obtained from the behavior of MCD associated variants. HCS catalytic 
activity in lysates obtained from MCD patients has been measured, usually using the 
bacterial carboxylase as a substrate. The variant enzymes display a wide range of 
defects that can affect both the catalytic activity and KM for biotin(39,55-58). Some of 
the mutations affect positions in the catalytic domain of HCS. Others affect positions 
in the N-terminus and stress the importance of this domain to HCS function. Some 
broad correlations have been drawn regarding the effects of mutations and clinical 
symptoms responsiveness to biotin therapy. Those mutations altering the N-terminus 
tend to affect the kcat (59), and to not respond as readily to biotin administration. Yet, 
a characterization regarding altered KM for the acceptor substrates is rarely 
performed, despite its importance as it provides an explanation for poor biotin 
responsiveness.  
 
1.2 The experimental problem 
In spite of HCS importance for biotin metabolism, biochemical 
characterization of HCS function has been lacking. These studies have been hindered 
by the lack of a method to obtain sufficient amounts of pure protein. In chapter 2, we 
describe the recombinant expression of FL-HCS and 58-HCS in E. coli and their 
subsequent purification. In addition, chapter 2 includes the design of several assays to 
perform a steady state kinetic characterization of the effects of p67 or the minimal 
carboxylase acceptor substrate, ATP and biotin concentrations. Stopped flow studies 
of each of the two half reactions catalyzed by HCS showed that bio-5‟-AMP 
 18 
 
synthesis is the limiting step in the overall reaction. The two isoforms behaved 
similarly in all the assays, except for biotin transfer from the intermediate to the PCC 
biotin acceptor protein, where FL-HCS was twofold faster than 58-HCS. This led to 
the conclusion that HCS N-terminus is involved in biotin acceptor substrate 
recognition and highlighted the importance of protein-protein interaction as a source 
of substrate specificity. 
Chapter 3 comprises a more detailed investigation of the biotin transfer 
reaction. The previous stopped flow experiments monitored the enzyme substrate 
disappearance and yielded information on the bimolecular rate of enzyme-substrate 
association. The same rates were obtained when monitoring product formation using 
tritium labeled biotin in a quench flow assay. This indicated that biotin transfer is 
limited by the bimolecular rate of enzyme-substrate association. Comparison to the 
results obtained with BirA, the E. coli enzyme, and PhBPL, an archaeal ligase, 
showed that this mechanistic aspect is conserved among evolutionary domains. In 
addition, the enzymes biotinylated the substrates from the other species with a wide 
range of rates, once again highlighting protein-protein interactions as the basis of 
selectivity in post-translational biotin addition.  
Insight into HCS substrate specificity among the various endogenous human 
substrates is presented in Chapter 4. HCS associated with the biotin acceptor 





. ACC1 and ACC2 behaved differently, with the chemistry of biotin 
transfer becoming the rate limiting step. The different behavior correlated with the 
carboxylases localization, since ACC1 and ACC2 are present in the cytoplasm, while 
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the other carboxylases are transported into the mitochondria. A model consistent with 
these observations is that HCS biotinylates PC, PCC and MCC enzymes faster 
because mitochondrial enzymes are only transiently present in the cytoplasm and 
should be post-translationally modified before they reach their final destination. 
Conversely, HCS has continuous access to ACC1 and ACC2, so there has not been 
any evolutionary pressure to increase the biotinylation reaction speed. In addition, the 
data suggest a molecular mechanism for the establishment of a hierarchy that 
determines biotin distribution among carboxylases based on the rates of bimolecular 
association. Carboxylases will compete for the biotin, and those that have the highest 
apparent rate of association, which will depend on substrate concentration and 


























Chapter 2: Biochemical characterization of FL-HCS and 58-
HCS 
The work presented in this chapter was originally published in the Journal of 
Biological Chemistry: Maria Ingaramo and Dorothy Beckett. Distinct Amino Termini 
of Two Human HCS Isoforms Influence Biotin Acceptor Substrate Recognition. 
Journal of Biological Chemistry. 2009; 284, 30862-30870.  the American Society 
for Biochemistry and Molecular Biology. 
 
2.1 Abstract 
The human holocarboxylase synthetase (HCS) catalyzes transfer of biotin to 
biotin-dependent carboxylases, and the enzyme is therefore of fundamental 
importance for many physiological processes, including fatty acid synthesis, 
gluconeogenesis, and amino acid catabolism. In addition, the enzyme functions in 
regulating transcription initiation at several genes that code for proteins involved in 
biotin metabolism. Two major forms of HCS exist in humans, which differ at the 
amino terminus by 57 amino acids. In this work, the two proteins were expressed in 
Escherichia coli, purified, and subjected to biochemical characterization. Equilibrium 
sedimentation indicates that the two proteins are monomers both in their apo-forms 
and when bound to the enzymatic intermediate biotinyl 5‟-AMP. Steady state kinetic 
analyses as a function of biotin, ATP, or a minimal biotin-accepting substrate 
concentration indicate similar behaviors for both isoforms. However, pre-steady state 
analysis of biotin transfer reveals that the full-length HCS associates with the minimal 
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biotin acceptor substrate with a rate twice as fast as that of the truncated isoform. 




Biotin protein ligases are enzymes that are required for viability of all 
organisms. In metabolism these enzymes catalyze covalent linkage of biotin to biotin-
dependent carboxylases as indicated in the following reactions, 
     
in which the adenylated derivative of biotin, biotinyl 5‟-AMP (bio-5‟-AMP), 
is first synthesized from the substrates biotin and ATP (23). In the second step, the 
enzyme·adenylate complex interacts with the biotin acceptor domain or subunit of a 
carboxylase, and the biotin is covalently linked to the -amino group of a specific 
lysine residue on the acceptor. In humans the ligase is referred to as holocarboxylase 
synthetase (HCS). 
Five biotin-dependent carboxylases, including acetyl-CoA carboxylases 1 and 
2, 3-methylcrotonyl-CoA carboxylase, pyruvate carboxylase, and propionyl-CoA 
carboxylase, are the HCS substrates in humans. The biotin moiety serves as the 
transient carboxylate carrier as it is transferred from a donor to an acceptor in the 
reaction catalyzed by each enzyme. Biotin-dependent carboxylase-catalyzed reactions 
contribute to fatty acid synthesis and oxidation, gluconeogenesis, and amino acid 
catabolism. Mutations in the HCS gene cause multiple carboxylase deficiency, a 
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potentially fatal disease characterized by the concurrence of symptoms associated 
with each individual carboxylase deficiency (60-61). 
In response to changes in biotin availability, HCS has been demonstrated to 
function in regulating transcription of the gene that encodes HCS itself as well as 
those that code for propionyl-CoA carboxylase, pyruvate carboxylase, acetyl-CoA 
carboxylase 1, and the sodium-dependent multivitamin transporter (48,62). This 
transcriptional regulatory process is associated with the soluble guanylyl cyclase 
signal transduction pathway (35). It has also been suggested that HCS exerts its 





















Figure 7. HCS function in metabolism and transcription regulation. The 
enzyme utilizes substrates biotin and ATP to catalyze synthesis of bio-5‟-AMP. The 
HCS·intermediate complex interacts with carboxylases to transfer biotin or functions 





Full-length HCS is a 726-amino acid polypeptide, characterized by a 
molecular mass of 81 kDa. Although residues 448–701 are homologous to the 
catalytic region of the Escherichia coli ligase, BirA (57), the sequence of the amino-
terminal 447 residues of HCS bears homology only to the amino-terminal sequences 
of other mammalian holocarboxylase synthetases. Although only one copy of the 
HCS gene is present per haploid genome, analysis of the 5‟ termini of cDNAs (38), 
elucidation of the structure of the HCS gene (39), and purification of HCS from 
human tissue (40) indicate the existence of more than one form of the protein. 
Characterization of HCS cDNAs revealed an mRNA in which the initiator codon 
corresponds to methionine 58 in the full-length coding sequence(38). In addition, 
Western blot analysis of partially purified HCS from human placenta revealed three 
species that were assigned to the full-length HCS protein (FL-HCS) and species that 
initiated translation at methionine 7 or methionine 58 (58-HCS) (40). 
The significance of these distinct HCS forms for functional biology is not 
known. It is possible that the two isoforms are characterized by different catalytic 
activities. Alternatively, the different forms may play distinct roles in the metabolic 
versus transcriptional functions of the enzyme. To investigate the enzymatic 
properties of the two isozymes, we have overexpressed and purified FL-HCS and 58-
HCS to homogeneity. Sedimentation equilibrium measurements of the two proteins 
indicate that each is monomeric in both the unliganded state and when saturated with 
the intermediate in biotin transfer, biotinyl 5‟-AMP. Steady state parameters 
governing the overall biotin transfer reaction using the model substrate p67, a 
fragment of propionyl-CoA carboxylase, show that they are very similar. However, 
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pre-steady state kinetic analysis of the second half-reaction revealed that FL-HCS 
associates with p67 at a faster rate than does 58-HCS. The results indicate that the 
two isoforms are functionally distinct and that the amino terminus influences the 
kinetics of interaction of the enzyme with the biotin acceptor protein. 
 
2.3 Experimental procedures 
 2.3.1 Chemicals and Biochemicals 
All chemicals used were at least reagent grade. The stock ATP solutions were 
prepared by dissolving ATP disodium salt (Sigma) into water and adjusting the pH to 
7.5. The nucleotide concentration was determined by UV spectroscopy using an 





Healthcare) was stored desiccated under nitrogen at −20 °C. Biotin D-2,3,4,6-
3
H was 
purchased from American Radiolabeled Chemicals, Inc., and stored at −20 °C. The 
bio-5‟-AMP was synthesized and purified as described previously (23,63). Protein 
extinction coefficients were calculated according to Gill and von Hippel (64). 
2.3.2 Expression Plasmid Construction 
The strategy developed to overexpress FL-HCS and 58-HCS involved 
constructing plasmids that encode amino-terminal his6-SUMO fusions of each protein 
using the linearized pSUMOpro (LifeSensors Inc.) expression vector (65). Primers 
containing an Esp3I restriction site were used to amplify the HCS coding sequences 
by PCR. The coding sequence for 58-HCS was amplified from a pGEX construct 
provided by Dr. Roy Gravel. The FL-HCS cDNA sequence (GenBankTM accession 
number NM_000411.4) was purchased from OriGene Technologies, Inc. After 
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digestion of the PCR product with Esp3I (Fermentas), the resulting two coding 
sequence fragments were ligated into the linearized pSUMO vector using T4 ligase 
(Roche Applied Science), and the ligation mixtures were transformed into the E. coli 
top10 strain. Plasmids were verified by sequencing the entire insert. 
2.3.3 Purification of 58-HCS and FL-HCS  
The plasmids encoding his6-SUMO-FL-HCS and his6-SUMO-58-HCS were 
transformed into E. coli RosettaTM(DE3). Once the culture had reached an A600 of 
0.6, induction was achieved by the addition of lactose (Difco) to a final concentration 
of 0.5% (w/v) and allowed to proceed for 18–20 h at 25 °C. Cells were harvested, 
resuspended in 30 ml of lysis buffer/liter of culture (50 mM sodium phosphate buffer, 
pH 8, 500 mM sodium chloride, 1 mM 2-mercaptoethanol, 1 mM 
phenylmethylsulfonyl fluoride, and 5% (v/v) glycerol containing 10 mM imidazole), 
and lysed with three French press passes at 800–1000 p.s.i. The cellular debris was 
pelleted by centrifugation, and the supernatant was loaded onto a Ni
2+
-Sepharose 
column (GE Healthcare). After washing extensively, 20 ml of lysis buffer containing 
1 mM ATP, 0.5 mM magnesium chloride, and 1 μM of the biotin acceptor protein 
p67 was loaded on the column to remove residual biotin and bio-5‟-AMP that was 
associated with the enzyme. After a wash step, the HCS protein was eluted with lysis 
buffer containing 400 mM imidazole. Sumo protease-1 (66) that was purified in this 
laboratory using an overexpression plasmid provided by Dr. C. Lima was added at a 
1:100 (w/w) ratio to the HCS, and the mixture was dialyzed into buffer containing 10 
mM sodium phosphate, pH 8.0, 60 mM NaCl, 5% (v/v) glycerol, 5 mM 2-
mercaptoethanol. Following overnight incubation, the imidazole concentration was 
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adjusted to 40 mM, and the sample was loaded again onto Ni
2+
-Sepharose resin to 
remove the his6-SUMO tag and the his6-tagged protease. The flow-through was 
collected and dialyzed against buffer containing 10 mM sodium phosphate, pH 8.0, 
30 mM NaCl, 1 mM 2-mercaptoethanol, 5% glycerol. The resulting sample was 
loaded onto a Toyopearl anion exchange column (Tosoh Bioscience) and eluted with 
a linear gradient to 0.3 M NaCl. HCS was concentrated and stored in 10 mM Tris-
HCl, pH 8, 200 mM sodium chloride, 10% glycerol at −80 °C. The yield was 2 mg of 
protein/liter of bacterial culture and the concentration of each protein was determined 
spectrophotometrically using an extinction coefficient at 280 nm of 56,610 M cm
−1
 
(64). The proteins were at least 97% pure as judged by Coomassie Brilliant Blue 
staining of samples subjected to SDS-PAGE. 
2.3.4 Purification of p67 
The pDest17 plasmid coding for his6-p67 was a generous gift from Dr. Roy 
Gravel. Purification of his6-p67 was carried out as described previously (67), except 
for the use of an additional SP-Sepharose Fast Flow column (GE Healthcare). This 
column was run with a linear KCl gradient in 50 mM Tris-HCl, pH 7.5, at 4 °C, 5% 
glycerol, 1 mM 2-mercaptoethanol. The concentration was determined 
spectrophotometrically using an extinction coefficient at 276 nm of 4350 M cm
−1
. 
The presence of biotinylated p67 in the preparations was undetectable, as determined 
by MALDI-TOF mass spectrometry using the α-cyano-4-hydroxycinnamic acid 
matrix (28). The same method was used to determine that all of the p67 preparation is 




2.3.5 Equilibrium Sedimentation Measurements 
Equilibrium sedimentation measurements were carried out in a Beckman 
Optima XL-I analytical centrifuge equipped with a 4-hole An60-Ti rotor (Beckman 
Coulter). Double sector 12-mm path length cells with charcoal-filled Epon 
centerpieces and sapphire windows were used. Samples (VTOT = 140 μl) were 
prepared at final concentrations ranging from 2 to 20 μM from protein that had been 
extensively dialyzed against reaction buffer (10 mM Tris-HCl, pH 7.50 ± 0.02 at 20.0 
± 0.1 °C, 200 mM KCl, 2.5 mM MgCl2). Samples that contained HCS, FL- or 58-, 
and bio-5‟-AMP were prepared with 1.5-fold molar excess of the ligand over the 
protein. Centrifugation was carried out at speeds ranging from 14,000 to 22,000 rpm 
for 12 h at each speed (68), and absorbance scans were acquired at 280 or 295 nm, if 
the bio-5‟-AMP contribution needed to be avoided, with a step size of 0.001 cm and 
five averages per step. The data obtained for the samples run at the multiple speeds 
were subjected to a global single species analysis using the program WinNonLin (69), 
and the best fit value of σ obtained from the analysis was converted to molecular 






in which M is the molecular mass  v  is the partial specific volume of the 
protein, ρ is the buffer density; ω is the angular velocity; R is the gas constant; and T 
is the temperature. The value of ρ (1.007 g/ml) was determined pycnometrically (70), 
and v  was calculated, based on the protein sequences, to be 0.7389 ml/g for 58-HCS 




2.3.6 Steady State Kinetic Measurements 
Kinetic measurements of the overall HCS-catalyzed reaction as a function of 
ATP or p67 concentration were performed by monitoring the incorporation of 
[
14
C]biotin into p67. The reactions were carried out in reaction buffer at 37.0 ± 0.1 °C 
and initiated by the addition of enzyme to a final concentration between 50 and 150 
nM. At designated time points, a 17-μl aliquot was quenched into a solution 
containing 5.1 μl of loading dye and 3.4 μl of 1% trifluoroacetic acid (in H2O). The 
loading dye was composed of 50 mM Tris-HCl, pH 6.8, 4% SDS, 30% glycerol, 0.67 
mg/ml Coomassie Brilliant Blue G-250, 735 mM 2-mercaptoethanol. Unincorporated 
[
14
C]biotin was separated from the 
14
C-biotinylated p67 by electrophoresis on a 16% 
acrylamide-SDS-Tricine gel (71). The gels were dried on Whatman 3MM paper and 
exposed to a phosphor screen (GE Healthcare) for 3 days. The phosphor screen image 
was scanned using a Storm PhosphorImager, and the volumes of the bands 
corresponding to [
14
C]biotin-labeled p67 were quantified using the ImageQuant 
software (GE Healthcare). Initial velocities were obtained from the slope of counts 
versus time plot. The initial velocity versus substrate concentration data were 
subjected to nonlinear least squares analysis using the Michaelis-Menten equation 
with GraphPad Prism to obtain Vmax and Km. The Vmax and kcat values were converted 
from counts/min to micromolars of biotin using the relation between counts/min and 
micromolars obtained from a reaction containing 50 μM p67, 150 nM HCS, 10 μM 
biotin, and 1 mM ATP in standard reaction buffer incubated for 1 h to allow complete 
incorporation of the biotin into the acceptor protein. In experiments in which the 
Michaelis-Menten constants for p67 were determined, the [
14
C]biotin and ATP 
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concentrations were set at saturating values of 10 μM and 1 mM, respectively. The 
Km and kcat values for ATP were determined in a similar fashion, with the exception 
that the reactions contained 50 μM p67, 10 μM [
14
C]biotin, and variable ATP 
concentrations. 
The biotin concentration dependences of the reactions catalyzed by FL- and 
58-HCS were determined by quantitating the incorporation of [
3
H]biotin into p67. 
Each reaction contained 16.67 nM [
3
H]biotin and a supplement of unlabeled biotin to 
obtain the desired final total biotin concentration. The p67 and ATP concentrations 
were 150 μM and 1 mM, respectively. Reactions were initiated by addition of enzyme 
to 5 nM final concentration, and aliquots were quenched with trifluoroacetic acid 
added to a final concentration of 0.3% (v/v). Quenched reactions were filtered though 
BA 85 Protran nitrocellulose membranes (Whatman), and the retained radioactivity 
was quantified in ProteinReady
+
 scintillation fluid (Beckman) using a LS6500 
Beckman counter. The measured disintegrations/min were converted to molar 
quantities of biotin incorporated by multiplying by total biotin concentration/dpm of 
unfiltered sample. The correction for filter retention was achieved by using the 
disintegrations/min associated with a filtered and unfiltered reaction in which 10 μM 
cold biotin and 16.67 nM [
3
H]biotin were fully incorporated into p67. 
2.3.7 Steady State Fluorescence Spectra 
Steady state fluorescence spectra were acquired at 20 °C in reaction buffer 
using an ISS PC1 instrument. The excitation wavelength was 295 or 300 nm, and 
emission was monitored from 310 to 450 nm. The excitation slit width was set to 4 or 
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8 nm, and the emission slit width was 8 nm. Spectra were corrected for contributions 
from buffer and ligand and for dilution. 
2.3.8 Initial Rate of Bio-5′-AMP Synthesis 
The rate of bio-5‟-AMP synthesis was measured at 20 °C by monitoring the 
intrinsic protein fluorescence decrease that accompanies synthesis of the intermediate. 
The experiments were performed in a Kintek 2001 stopped flow instrument using an 
excitation wavelength of 295 or 300 nm and monitoring the emission through a 340-
nm cutoff filter (Corion Corp.). Several ATP solutions prepared at concentrations 
ranging from 25 to 800 μM were rapidly mixed in a 1:1 ratio with a solution of a 
fixed concentration of HCS containing 30 μM biotin. Initial HCS concentrations 
varied from 2 to 6 μM, and all solutions were prepared in degassed reaction buffer. A 
minimum of five traces that spanned at least eight half-lives of the process was 
collected at each ATP concentration. Transients were analyzed using a double 
exponential function with the Kintek software. The dependences of the apparent rates 
of the two phases on ATP concentration are discussed under “Results.” 
2.3.9 Measurement of the Bimolecular Association Rate Constant of HCS with 
p67 
The bimolecular rate of association of HCS with p67 was obtained by 
monitoring the intrinsic fluorescence increase of HCS upon depletion of the bio-5‟-
AMP·HCS complex. The instrument and experimental setup were as described above, 
with the exception that one syringe contained varying concentrations of p67, and the 
second syringe contained a fixed concentration of the HCS·bio-5‟-AMP complex. 
The HCS·bio-5‟-AMP complex concentration before mixing ranged from 1 to 3 μM 
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in different experiments. This solution was prepared by combining HCS with biotin at 
half of the enzyme concentration and 100 μM ATP and incubating for 10 min to 
allow completion of bio-5‟-AMP synthesis. This solution was rapidly mixed with 
p67, and the resulting time-dependent increase in intrinsic HCS fluorescence was 
monitored. At least five traces acquired at each [p67] were fit to single exponential to 
obtain apparent rates. The observed rates as a function of p67 concentration were 
subjected to further analysis as described under “Results.” 
 
2.4 Results 
2.4.1 Purification of HCS Isoforms 
The two HCS isoforms were expressed in E. coli as his6-SUMO fusion 
proteins, and the purification protocol, which included three chromatography steps, 
yielded preparations that were >97% pure (Fig. 8). Because SUMO-protease-1 leaves 
no exogenous amino acids after cleavage, the final proteins correspond to native 58-
HCS and FL-HCS. In the purification, it was necessary to incorporate steps to remove 
bio-5‟-AMP from the preparations. This contamination was revealed by the ability to 
detect biotinylation of p67 in the absence of added biotin. Biotinylation was assayed 
as a shift in the mass of a fraction of the p67 using MALDI-TOF mass spectrometry. 
Both the E. coli and Pyroccocus horikoshii enzymes have been purified in this 
laboratory, and in contrast to the Homo sapiens enzyme, no contaminating substrate 








Figure 8. SDS-polyacrylamide gel of 58-HCS purification fractions. A, lane 1, 
low range molecular weight markers (Bio-Rad). Lane 2, crude extract after induction. 
Lane 3, sample obtained from the first Ni
2+
-Sepharose column. Lane 4, sample after 
SUMO protease 1 cleavage. Lane 5, flow-through from the second Ni2
+
-Sepharose 
column. Lane 6, material obtained after Toyopearl anion exchange column. B, 12% 
SDS-polyacrylamide gel of the pure proteins. Lane 1, low range molecular weight 
markers. Lane 2, FL-HCS; lane 3, 58-HCS. 
 
 
2.4.2 Sedimentation Equilibrium Analysis of FL-HCS and 58-HCS Oligomeric 
State 
 Sedimentation equilibrium measurements were used to determine the 
oligomeric state of the two HCS enzymes in reaction buffer at 20 °C. Scans obtained 
for unliganded 58-HCS are shown in Fig. 9, along with the results of nonlinear least 
squares analysis of the data. Global analysis of data obtained for samples prepared at 
two protein concentrations and centrifuged at two rotor speeds using a single species 
model indicates a molecular weight consistent with the monomer. The experimentally 
determined molecular masses were 74 ± 4 and 83 ± 3 kDa for 58-HCS and FL-HCS, 
respectively. These values agree within error with the analytical molecular masses of 






Figure 9. HCS analytical ultracentrifugation. Concentration distribution for 
3.8 μM 58-HCS in reaction buffer at 20 °C. Absorbance versus radial position 
obtained at rotor speeds of 18,000 rpm (○) and 22,000 rpm (∙). The solid lines 
represent the best fit of the data acquired at 3.8 and 1.9 μM 58-HCS and the two rotor 











The E. coli biotin protein ligase undergoes a monomer-dimer transition that is 
dependent on bio-5‟-AMP binding  (70). To investigate the effect of the intermediate 
on the self-association of the two HCS enzymes, sedimentation equilibrium 
measurements were performed in the presence of excess bio-5‟-AMP. The 
experimentally obtained molecular masses for the intermediate bound species were 79 
± 8 kDa for 58-HCS and 83 ± 7 kDa for FL-HCS, consistent with a monomeric 
species. Thus, both the unliganded and intermediate-bound forms of FL and 58-HCS 
are monomeric. 
2.4.3 Kinetic Analysis of the Two-step HCS-catalyzed Reaction 
In the HCS-catalyzed reaction, biotin is covalently linked to a specific lysine 
residue on the biotin carboxyl carrier protein domain of five distinct carboxylases. 
The physiologically relevant substrates contain multiple copies of this domain. To 
develop a simple assay for measuring the catalytic activity of the purified HCS 
enzymes, the p67 domain of propionyl-CoA carboxylase was employed as the model 
acceptor substrate. This protein corresponds to the carboxyl-terminal 67 residues of 
the α subunit of human propionyl-CoA carboxylase, which contains sufficient 
information for recognition by the human biotin protein ligase (72). 
The two kinetic assays used in this work rely on measurements of 
incorporation of radiolabeled biotin into p67. In the first assay, [
14
C]biotin 
incorporation into p67 was monitored. The [
14
C]biotin-labeled p67 was separated 
from the unincorporated biotin by electrophoresis, and radioactivity in the bands 
corresponding to p67 was quantitated by phosphorimaging (Fig. 10A). The initial rate 
at several ATP concentrations and constant biotin and p67 concentrations exhibit the 
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expected increase in the rate of [
14
C]biotin incorporation with increasing ATP 





Figure 10. Kinetic assays used to determine Michaelis-Menten constants for 
HCS-catalyzed biotin transfer with respect to p67, biotin, and ATP. A, incorporation 
of [
14
C]biotin into p67 was used to determine the kinetic constants with respect to p67 
and ATP. The biotinylated p67 and free biotin are separated on a 16% acrylamide gel. 
B, biotin incorporation versus time at 150 nM 58-HCS, 50 μM p67, 10 μM 
[
14
C]biotin, and a range of ATP concentrations as follows: (■, 5 μM; ▴, 30 μM; ▾, 90 
μM; ♦, 250 μM; ∙, 500 μM; □, 750 μM; and ▵, 1000 μM ATP. C, incorporation of 
[
3
H]biotin into p67 used to determine the kinetic constants with respect to biotin. 
Biotinylated p67 is separated from unincorporated biotin by filtration through a 
nitrocellulose membrane. D, initial rates of biotin incorporated measured at 5 nM FL-
HCS, 150 μM p67, 16.67 nM [
3
H]biotin and variable unlabeled biotin concentrations 
as follows: ▾, 20 μM; ■, 10 μM; ♦, 7 μM; ∙, 3 μM; and ▴, 1 μM biotin. The inset 
depicts the traces obtained for the following: ▿, 400 nM; Δ, 150 nM; and ◊, 50 nM 
total biotin. B and D, the lines were obtained from linear regression of the measured 




The second assay for HCS catalytic activity monitors [
3
H]biotin incorporation 
into p67. The [
3
H]biotin-labeled p67 was separated from the unincorporated biotin by 
filtration through nitrocellulose and quantitated by liquid scintillation counting (Fig. 
10C). The relatively low Km value for biotin, the detection limit of the 
14
C radiation 
using phosphorimaging, and a new lack of commercial availability of the [
14
C]biotin 
motivated development of this second assay. Results of measurements of the initial 
rates of HCS-catalyzed [
3
H]biotin incorporation at constant ATP and p67 
concentrations and varying total biotin concentrations are shown in Fig. 10D. The 
time courses used for initial rate measurements at low biotin concentrations were 
carried out for a shorter time than those acquired at the higher biotin concentration. 
This is due to the higher specific activity of the substrate at the low cold biotin 
concentration, which allowed acquisition of data over shorter time periods. 
To investigate if the amino-terminal 57-amino acid residues impact the basic 
catalytic properties of the human biotin protein ligase, the kinetic parameters 
associated with the process were measured for both FL-HCS and 58-HCS. 
Measurements of the initial rates of biotin transfer as a function of p67 concentration 
are shown in Fig. 11, A and B. The results indicate Km values of 19 and 21 μM, 
respectively, for FL-HCS and 58-HCS (Table 1) and values of kcat that are similar at 
0.47 and 0.35 s
−1







Figure 11. Steady state kinetic analysis of biotin incorporation into p67 
catalyzed by 58-HCS and FL-HCS. Samples of steady state analysis of the reaction 
catalyzed by 58-HCS (A) and FL-HCS (B) as a function of p67 concentration are 
shown. Data were obtained as a function of ATP concentration for 58-HCS (C) and 
FL-HCS (D). E and F display results of steady state measurements for 58-HCS and 
FL-HCS as a function of biotin concentration. In these two panels each data point 
represents the average of the initial rate measured at each biotin concentration in three 
independent experiments. In E and F, the error bars represent the standard deviation 
of each three points. In each panel the solid line represents the best fit of the data to 








Table  1. Kinetic parameters for the overall HCS-catalyzed reaction. 
 
HCS form Substrate        KM          kcat     kcat/ KM 
         M 
 









58 p67 19    ±   4
a
   0.35 ± 0.02
a
   1.8 ± 0.4 
 ATP 41    ± 10
a
   0.33 ± 0.02
a,b
   0.8 ± 0.2 
    (0.24 ± 0.01)
a,c
   0.6 ± 0.1 
 biotin   0.7 ±   0.3
d
   0.11 ± 0.01
d
 16    ± 7 
     
FL p67 21    ±   2
 a
   0.47 ± 0.01
 a
   2.2 ± 0.2 
 ATP 47    ±   8
 a
        0.45 ± 0.02
a,b 
 (0.32 ± 0.01)
a,c
 
  1.0 ± 0.2 
  0.7 ± 0.1 
 biotin   0.8 ±   0.2
d
   0.17 ± 0.01
d
 21    ± 5 
     
 
a
 The errors correspond to the standard deviation of two independent experiments.
b
 
The calculated value is based on the experimentally obtained kcat at 50 μM p67.
c
 
Experimentally obtained kcat was at 50 μM p67.
d
 The error represents the standard 
error obtained from globally fitting data from three independent experiments.  
 
 
A similar analysis as a function of ATP concentration (Fig. 11, B and D) 
provides Km values for ATP of 41 and 47 μM for 58-HCS and FL-HCS, respectively. 
The magnitude of kcat associated with ATP obtained from direct fitting of the data is 
lower than that obtained from measurements of the p67 concentration dependence of 
the reaction. This is attributable to the necessity, due to the appearance of a doublet 
for the labeled p67 at high concentrations, of using an acceptor protein concentration 
of 50 μM in the ATP concentration dependence measurements. Normalization of the 
resolved kcat values obtained from analysis of the ATP concentration dependence of 
the reactions to those obtained from the measurements of the p67 concentration 
dependence reveals that they are identical (Table 1). 
The FL-HCS and 58-HCS enzymes were subjected to Michaelis-Menten 





results of measurements of the initial rates versus biotin concentration indicate that 
both FL- and 58-HCS-catalyzed reactions are well described by a Michaelis-Menten 
model (Fig. 11, E and F). The initial rate at each biotin concentration represents the 
average of at least three independent measurements. Results of nonlinear least squares 
analysis of the data indicate that the two enzymes are similar with respect to their rate 
versus biotin concentration profiles. The kcat values resolved from the analysis are ~3-
fold lower than those obtained from analysis of data obtained using SDS-PAGE to 
separate products from reactants. Because p67 and ATP concentrations used in the 
measurements were saturating, the differences in the values of kcat reflect differences 
intrinsic to the two assays. 
2.4.4 Pre-steady State Analysis of Bio-5′-AMP Synthesis 
The overall reaction catalyzed by HCS can be classified as a ping-pong 
mechanism, which allows measurement of the two individual half-reactions. Upon 
bio-5‟-AMP synthesis, decreases in intrinsic protein fluorescence of ~14% for FL-
HCS and 23% for 58- HCS are observed (Fig. 12A). A stopped flow experiment was 
developed to investigate the first half-reaction, in which biotin-bound HCS was 
rapidly mixed with ATP. Measurement of the time dependence of the fluorescence 
decrease revealed that it was well described by a double exponential model (Fig. 12A, 
inset). A loss in amplitude with increasing ATP concentration was observed, which 
was attributed to the faster phase becoming increasingly fast and outside of the dead 
time of the stopped flow instrument. The apparent rates for the two phases were 
plotted as a function of ATP concentration (Fig. 12B). The observed linear 
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dependence of the faster phase on ATP concentration and the saturable slower phase 
are consistent with the following reaction, 
 
   
 
in which the slope of the linear dependence of the apparent rate of the fast 
phase on nucleotide concentration provides an estimate of the rate of association of 
ATP with the HCS·biotin complex, k1 (Table 2). Nonlinear least squares analysis of 
the concentration dependence of the second phase using the Michaelis-Menten model 
yielded kcat and Km values for the reaction. The parameters obtained for 58-HCS and 







Figure 12. Pre-steady state analysis of bio-5‟-AMP synthesis. A, fluorescence 
(arbitrary units) emission spectra of 1.5 μM HCS and 15 μM biotin before (solid line) 
and after (dashed line) addition of 100 μM ATP. Inset, representative stopped flow 
fluorescence (arbitrary units) trace obtained upon mixing 2 μM HCS and 30 μM 
biotin with 25 μM ATP. B, dependence of the apparent rate of bio-5‟-AMP synthesis 
on ATP concentration. The line is the fit to the Michaelis-Menten equation. Inset, 














Table 2. Kinetic parameters for ATP dependence of bio-5‟-AMP synthesis 
 
 







        M 
 









58 4.9 ± 0.7
a
     50 ± 30
a





2 ± 1 
8 ± 5 
FL 6    ± 1
c
     50 ± 20
c





2 ± 1 
7 ± 3 




The errors correspond to the standard deviation for two independent experiments.
b
 
The calculated kcat values were obtained at 37 °C assuming that the rate doubles every 
10 °C.
c




2.4.5 Single Turnover Analysis of the Biotin Transfer Reaction 
The second half-reaction, transfer of biotin from bio-5‟-AMP to p67, was also 
measured using stopped flow fluorescence. An increase in intrinsic protein 
fluorescence, which reports on depletion of the enzyme-intermediate species, occurs 
upon addition of p67 to the pre-formed HCS·bio-5‟-AMP complex (Fig. 13A). In the 
measurements, HCS was first allowed to synthesize bio-5‟-AMP from ATP and 
biotin. To ensure single turnover conditions, the biotin concentration used was half 
that of the HCS concentration. Moreover, because at micromolar protein 
concentrations HCS is at stoichiometric conditions with respect to bio-5‟-AMP 
binding, virtually all of the intermediate is associated with HCS. The 
HCS·intermediate complex was rapidly mixed with varying concentrations of p67 
under pseudo first-order conditions, and the resulting time-dependent increase in 
fluorescence was well described by a single exponential model (Fig. 13A, inset). The 
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amplitudes of the transients displayed no dependence on p67 concentration, 
indicating that the reaction goes to completion at all concentrations. Measurements 
performed over a large range of p67 concentrations up to 100 μM yield apparent rates 
that show no indication of leveling off (Fig. 13B). As a result, the fluorescent signal 
was interpreted as reporting on the initial p67 binding event that is governed by k1 in 
the following reaction, 
 
    
 
The slope of the line relating the dependence of the apparent rate on p67 
concentration provides a bimolecular rate constant for association of p67 with FL-





Figure 13. Single turnover measurements of biotin transfer from bio-5‟-AMP 
to p67. A, fluorescence emission spectra (arbitrary units) of 1 μM 58-HCS, 0.5 μM 
biotin, and 100 μM ATP before (solid line) and after (dashed line) addition of 10 μM 
p67. Inset, representative stopped flow fluorescence trace (arbitrary units) obtained 
upon mixing 1 μM 58-HCS, 0.5 μM biotin, and 100 μM ATP with 20 μM p67. B, 
dependence of the apparent association rate of FL-HCS-bio-5-AMP (∙) or 58-HCS-
bio-5‟-AMP (■) with p67 on acceptor protein concentration. Error bars represent the 







Table 3. Bimolecular association rate constants for HCS·bio-5‟-AMP with p67. 
 
HCS form          k1 








58    7.6 ± 0.6
a
 










Elucidation of the biochemical details of human holocarboxylase synthetase 
function has implications for understanding the mechanism of the metabolic disorder, 
multiple carboxylase deficiency, as well as how this metabolic enzyme functions in 
transcription regulation. The significance of the existence of multiple forms of the 
enzyme for its distinct roles also merits further study. The results presented in this 
work indicate that although the two HCS isoforms catalyze the first of the two half-
reactions in post-translational biotin addition with similar rates, they differ in the 
second half-reaction. Thus, the 57 amino-terminal residues appear to be involved in 
biotin acceptor protein recognition. 
2.5.1 FL-HCS and 58-HCS Are Monomeric 
Results of sedimentation equilibrium measurements indicate that in the 
micromolar concentration range both enzymes are monomeric regardless of ligation 
state. This result contrasts with that obtained for the E. coli enzyme, which 
homodimerizes in response to the adenylate binding (70). However, 
homodimerization of the E. coli enzyme is associated with the site-specific DNA 
binding function of the enzyme, a function that the human enzyme does not possess. 
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Studies of a number of simple monofunctional bacterial biotin protein ligases that do 
not possess a DNA binding domain indicate that they can exist as monomers or 
constitutive dimers. The structures of the dimeric enzymes, which utilize a surface 
distinct from that used by the E. coli enzyme to homodimerize, reinforce the idea that 
linkage of dimerization of the E. coli enzyme to bio-5‟-AMP binding is idiosyncratic 
to its additional role in site-specific DNA binding. 
Sedimentation analysis of the two HCS isoforms indicates that the HCS amino 
terminus plays no role in mediating homo-oligomerization of the protein. Several 
eukaryotic biotin protein ligases have been characterized at the sequence level. 
However, very few have been purified. Among these are the Saccharomyces 
cerevisiae and one of the two Arabidopsis thaliana enzymes. The chloroplastic A. 
thaliana enzyme has been overexpressed in and purified from E. coli and found to be 
monomeric in its native form (73). No characterization of the oligomeric state of the 
yeast enzyme was reported. Like the human enzyme, these eukaryotic enzymes are 
characterized at the primary structure level by a carboxyl terminus that is homologous 
to the monofunctional bacterial enzymes and the central and carboxyl-terminal 
domains of the bifunctional bacterial enzymes. Furthermore, they all possess amino-
terminal segments of varying lengths. One potential role for these amino-terminal 
segments is in self-association of the protein. However, the characterization of the 
purified human and plant enzymes indicates that this is not the case. 
2.5.2 Steady State Analysis of the Overall HCS-catalyzed Reaction 
The FL- and 58-HCS isoforms exhibit similar kinetic properties in the overall 
biotin transfer reaction. However, the kcat values for FL-HCS are consistently larger 
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than those measured for the truncated protein. For example, the kcat values of 0.35 ± 
0.02 and 0.47 ± 0.01 s
−1
 for 58-HCS versus FL-HCS, respectively, were resolved 
from measurements of the p67 concentration dependence of the reaction. Similarly 
modest differences in kcat are observed in measurements of the dependence of the rate 
on ATP and biotin concentrations. 
The values of the kinetic constants for two of the three substrates compare 
reasonably well with those reported previously for the human enzyme. However, the 
caveat to any comparison is that previous measurements were performed in 
fractionated cellular extracts. Previously reported values of the Km for biotin range 
from 15 nM to 1 μM and thus are in the same range as the values of 700–800 nM 
reported in this work (74-77). The Km values for ATP measured for FL-HCS and 58-
HCS are ~40–50 μM, although previously reported values range from 190 to 250 μM 
(74-75). Finally, the Michaelis constants for p67 reported in this work cannot be 
compared with any other values because none exist in the literature. 
2.5.3 Analysis of HCS Two Half-reactions 
Transient state kinetic analysis can yield valuable insight into a reaction 
mechanism. This method relies on the use of high enzyme concentrations that allow 
the direct detection of intermediates. As a result, the analysis makes possible the 
determination of elementary rate constants(78). In this work, two transient state 
assays were used to obtain information on the two half reactions. The assay for bio-
5‟-AMP synthesis is based on rapidly mixing a large concentration of enzyme 
saturated with excess biotin with several ATP concentrations. Although the set up 
resembles an „approach to steady state‟ experiment, the observed fluorescence change 
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indicates that on the examined timescale, a single turnover of bio-5‟-AMP synthesis 
is observed. In the biotin transfer assay, a constant concentration of biotin is pre-
incubated with twice as much enzyme and ATP to allow synthesis of bio-5‟-AMP. 
This complex is rapidly mixed with p67 prepared at several concentrations.  The 
excess enzyme allows for monitoring of only one reaction turnover.  
Results of the pre-steady state measurements of the first half-reaction indicate 
that the two forms synthesize bio-5‟-AMP with similar rates and Km for ATP. 
Furthermore, the Michaelis constants for ATP for the half-reaction are the same as the 
values obtained for the overall reaction. Because the fluorescence signal at this 
temperature was more reliable, measurements of the half-reactions were performed at 
20 °C. Assuming that the rate doubles every 10 °C, the values of kcat for the first half-
reaction at 37 °C are predicted to be 0.39 ± 0.06 s
−1
 for 58-HCS and 0.36 ± 0.06 s
−1
 
for FL-HCS. These values agree with those obtained from measurements of the 
overall reaction and therefore indicate that bio-5‟-AMP synthesis is the rate-limiting 
step in the two-step reaction. 
Stopped-flow fluorescence measurements of second half-reaction, which 
report only on association of p67 with the enzyme·intermediate complex, indicate that 
FL-HCS associates with the acceptor protein at a rate twice that measured for 58-
HCS. Furthermore, the absence of a leveling off of the rate as p67 concentration is 
increased is consistent with the conclusion that bio-5‟-AMP synthesis is the rate-
limiting step in the two-step reaction. Simulations of the kinetic time courses in the 
context of the model used for the analysis indicate a lower limit for the rate of biotin 
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transfer and product release of 1 s
−1
, a value significantly greater than the kcat value of 
0.1 s
−1
 determined for the first half-reaction. 
The distinct rates of association of FL- and 58-HCS with p67 are qualitatively 
consistent with the results of previous studies in which a series of truncation proteins 
of 58-HCS were characterized with respect to their abilities to catalyze biotin linkage 
to the biotin acceptor domain of the human propionyl-CoA carboxylase, p67, and the 
E. coli biotin carboxylase carrier protein fragment, BCCP87, of acetyl-CoA 
carboxylase (41). Those studies indicate that the amino-terminal region of the enzyme 
functions in dictating the relative specificity of the enzyme for the alternative 
acceptor protein substrates. However, in those studies, the physiologically relevant 
HCS forms, FL and 58, were not compared, and no time dependence was 
investigated. 
2.5.4 Implications of the Distinct Rates of Association of 58-HCS and FL-HCS 
with p67 
The most significant difference observed between FL-HCS and 58-HCS lies 
in the parameters describing their association with p67, with FL-HCS associating 
with the biotin acceptor substrate at a rate ~2-fold faster than 58-HCS. Although this 
difference is small, it may have consequences for the metabolic activities of 
carboxylases. The low biotin concentration in human tissue (nanomolar range) limits 
the supply of the HCS·bio-5‟-AMP complex (79-80). Once the complex is formed, 
biotin utilization by the carboxylases depends, in part, on the efficiency with which it 
is transferred from the intermediate to the acceptor protein substrates. There are five 
biotin-dependent carboxylases present in mammalian cells that are involved in a 
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variety of distinct metabolic processes. A hierarchy of recognition of these 
carboxylases by HCS may exist, depending on how vital the reaction is to the survival 
of the cell. In addition, there is currently no information about the relative abundance 
of FL- and 58-HCS, each with its distinct rate of association with acceptor protein 
targets. Tissue-specific variation in the availability of the two isoforms could 
potentially provide a means of regulating activities of biotin-dependent carboxylases. 
Other possible roles exist for distinct forms of the HCS. The function of HCS 
in transcription regulation is consistent with a nuclear role for the enzyme. Indeed, 
immunofluorescence studies indicate that the enzyme is localized to both the cytosol 
and the nucleus (43). The alternative HCS forms could be functionally distinct with 
regard to nuclear localization and, consequently, their relative significance for 
metabolism and transcription regulation. 
In conclusion, the work presented here has established that two naturally 
occurring isoforms of HCS behave similarly in most respects, but they have distinct 
activities in biotin acceptor substrate binding, thus indicating a role for the amino-
















Chapter 3: The biotin transfer reaction across different species 
 
The work presented in this chapter was originally published in the Journal of 
Biological Chemistry: Maria Ingaramo and Dorothy Beckett. Biotinylation: a post-
translational modification controlled by the rate of protein:protein association. 
Journal of Biological Chemistry. 2011; 286, 13071-13078.  the American Society 
for Biochemistry and Molecular Biology. 
 
3.1 Abstract 
Biotin protein ligases catalyze specific covalent linkage of the coenzyme 
biotin to biotin-dependent carboxylases.  The reaction proceeds in two steps including 
synthesis of an adenylated intermediate followed by biotin transfer to the carboxylase 
substrate.  In this work specificity in the transfer reaction was investigated using 
single turnover stopped-flow and quench-flow assays.  Cognate and non-cognate 
reactions were measured using the enzymes and minimal biotin acceptor substrates 
from E. coli, P. horikoshii  and H. sapiens. The kinetic analysis demonstrates that for 
all enzyme-substrate pairs the bimolecular rate of association of enzyme with 
substrate limits post-translational biotinylation. In addition, in noncognate reactions 
the three enzymes displayed a range of selectivities. These results highlight the 
importance of protein-protein binding kinetics for specific biotin addition to 






Post-translational protein modification is ubiquitous in biology and influences 
critical processes including metabolism, protein degradation and gene expression. 
The water soluble vitamin biotin, a required cofactor for biotin dependent 
carboxylases, functions as a transient carrier of carboxyl groups in their transfer from 
bicarbonate to small molecule metabolites, such as acetyl-CoA. The five mammalian 
biotin-dependent carboxylases function in gluconeogenesis, amino acid catabolism, 
and fatty acid synthesis and degradation (11). In its coenzyme function biotin must be 
covalently linked to a carboxylase in a highly specific post-translational modification 
reaction catalyzed by Biotin Protein Ligases (BPL). In this two-step reaction (figure 
14A) an intermediate, bio-5‟-AMP, is first formed from biotin and ATP substrates 
and the biotin is then linked via its carboxyl group to the ε amine of a specific lysine 
residue on the carboxylase (23). The target lysine residue is on the biotin carboxylase 
carrier protein (BCCP) domain of the carboxylase, an enzyme complex composed of 
multiple copies of BCCP, biotin carboxylase (BC),  and carboxyl transferase (CT) 
moieties (11).   
Previous studies of specificity in post-translational biotin addition are 
inconclusive.  In any single organism, with few exceptions, only the specific target 
lysine on carboxylase substrates is biotinylated. Consistent with this specificity, the 
Pyrococcus horikoshii ligase:BCCP structure, in which BCCP refers to a minimal 
biotin accepting domain, is characterized by an extensive protein:protein interface 
(34).  However, a lack of specificity is evident from numerous examples of 
interspecies biotinylation. For example, in vivo the Escherichia coli  ligase 
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biotinylates BCCP domains from yeast  (81), human  (72), plant  (82) and other 
bacteria  (83), and the human p67, a commonly used substrate that includes 
propionyl-CoA carboxylase BCCP, can be biotinylated by partially purified BPLs 
from at least nine other organisms  (38,84).  This inter-species biotinylation may be 
attributable to the high degree of sequence conservation among ligases and BCCP 
domains. Alternatively, the qualitative nature of the methods used to measure inter-
species reactivity may have precluded detection of selectivity in the reaction.  
Comparison of BPL-BCCP pairs from E.coli (Ec),  Pyrococcus horikoshii 
(Ph) and  Homo sapiens, which represent  three phylogenetic domains, illustrates the 
sequence and structural conservation among the enzymes and  substrates.  For 
example, the most disparate ligase catalytic domain sequences of E. coli and human 
(figure 14B) maintain 26 % sequence identity  and 43 % similarity  (85). Moreover, 
the structures of the catalytic domains of the  Ec and  Ph enzymes are nearly 
superimposable  (24,86). Overlay of BCCP structures  from the three organisms  
reveals that, with the exception of the “thumb” on the E. coli domain, they are 
identical (figure 15A). At the primary sequence level (figure 15B), the most disparate 
BCCP sequences from human and E. coli display 35 % identity and 54 % similarity 







Figure 14. Ligases across evolutionary domains. A. Ligase catalyzed biotin transfer 
occurs in two steps in which an activated biotin intermediate is first synthesized from 
ATP and biotin with the release of pyrophosphate. In the second step, the biotin 
moiety of bio-5‟-AMP is covalently attached to a specific lysine residue on BCCP. B. 
Alignment (87) of the E. coli, H. sapiens and P. horikoshii Biotin Protein Ligase 
catalytic domain sequences. The identities (black) and similarities (grey) are 










Figure 15. Alignment of structures and sequences of BCCP fragments. A. 
Superimposition of PhBCCP (grey, 2EJG), HsBCCP (dark grey, 2JKU) and EcBCCP 
(light grey, 1A6X) structures generated with Pymol software (http://www.pymol.org). 
B. Sequence alignment of the three BCCPs, generated using Jalview(87-88). The 
working HsBCCP sequence has an exogenous tyrosine residue at the N terminus, 










As indicated above, ligase-catalyzed biotinylation occurs in two steps and 
steady-state measurements with the human ligase revealed that bio-5‟-AMP synthesis 
is the rate limiting step in the overall reaction.  However, a single-turnover stopped-
flow fluorescence assay in which the preformed enzyme intermediate complex is 
mixed with the BCCP substrate provides specific information about the ligase-
acceptor protein interaction independent of the bio-5‟-AMP synthesis step. Stopped-
flow measurements of the HsBPL catalyzed biotin transfer from the intermediate to a 
human BCCP substrate revealed a linear dependence of the apparent rate on substrate 
protein concentration with no evidence of saturation (28,32). The simplest 
interpretation of this kinetic behavior is that the assay reports on the bimolecular 
collision of the enzyme with substrate protein. However, it is not known if this is a 
general feature of the BPL-catalyzed reaction. Additionally, the stopped-flow 
measurements, which monitor the disappearance of the enzyme:intermediate 
complex,  provide no information about product accumulation in the reaction, and, 
consequently, about which step limits turnover in the second half reaction.  
In this work, the single turnover stopped flow and a quench flow assay that 
allows monitoring of product formation are applied to studies of the second step in 
BPL-catalyzed biotinylation. Measurements performed on three cognate enzyme-
substrate pairs from E. coli, P. horikoshii and H. sapiens yield linear rate versus 
substrate concentration profiles in both assays. Furthermore, for each cognate 
enzyme.acceptor protein pair the bimolecular rates obtained using the stopped-flow 
and quench-flow assays are identical.  Thus, bimolecular association of the enzyme-
intermediate complex with BCCP substrate limits post-translational biotin transfer 
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from bio-5‟-AMP to the acceptor protein. In addition, measurements performed on 
noncognate enzyme-substrate pairs reveal distinct levels of substrate selectivity by the 
three enzymes. The control of the biotin transfer rate by enzyme-substrate collision 
coupled with the discrimination in noncognate reactions stresses the importance of 
protein:protein  recognition in post-translational biotin addition and has implications 
for control of biotin distribution in metabolism.   
  
3.3 Experimental Procedures  
 3.3.1 Chemicals and Buffers 
All chemicals used in buffer preparation were at least reagent grade. Bio-5‟-
AMP was synthesized and purified as previously described (23,63). Biotin d-[2,3,4,6-
3
H] was purchased from American Radiolabeled Chemicals, Inc and stored under 
argon at  -70
o
C. Unlabeled d-biotin and ATP were obtained from Sigma-Aldrich. The 
ATP concentration in stock solutions, which were prepared by dissolving adenosine 
5‟-triphosphate disodium salt into water and adjusting the pH to 7.5, were determined 
by UV absorbance using an extinction coefficient at 259 nm of 15400 M cm
-1
. Biotin 
solutions were prepared by dissolving the desired amount of powder in reaction 
buffer that had not been pH adjusted, adjusting the pH to 7.5, and bringing the 
solution to its final volume in a volumetric flask. The biotin stock was filtered, 
divided into 1 mL aliquots, and stored at -70 °C. The reaction buffer is composed of 
10 mM Tris-HCl pH 7.50±0.02 at either 20 
o
C (Ec, Hs) or 40 
o
C (Ph), 2.5 mM 
MgCl2, and 500 mM KCl (Ph) or 200 mM KCl (Ec, Hs).  
 59 
 
3.3.2 Protein expression and purification 
PhBPL, EcBPL and HsBPL were recombinantly expressed and purified from  
Escherichia coli as previously described  (31-32,89). The  E. coli biotin acceptor 
substrate fragment EcBCCP, which comprises the C-terminal 87 amino acids of the 
acetyl-CoA carboxylase BCCP subunit, was purified as in Nenortas  et al.  (28). All 
chromatographic steps were carried out on an AKTA prime FPLC platform at 4 °C 
(GE healthcare).  
PhBCCP corresponds to the 73 C-terminal amino acids of  P. horikoshii 
BCCP domain of acetyl-CoA carboxylase and was expressed from a pet11-a plasmid 
derivative that was a generous gift from Riken  (90). The plasmid was transformed 
into  E. coli BL21(λDE3)-RIL strain by electroporation and selection was carried out 
on Luria-Bertani (LB) agar plates containing 50 µg/ml kanamycin. A 1 mL volume 
from a 5 mL overnight culture was diluted into 50 mL of LB media containing 
antibiotic and grown for 8 hours at 37°C with shaking at 250 rpm. A second 500 mL 
culture was started by addition of 10 mL of the previous growth and grown overnight. 
The final four 1 L cultures were inoculated with the previous  culture at a dilution of 
1:20.  Protein expression was induced at an OD600 of 0.7 by addition of IPTG to 350 
µM, and allowed to proceed for 2.5 hrs. Cells were harvested by centrifugation at 
7000 rpm at 4 °C for 40 minutes, the pellet washed with 40 mL of lysis buffer per 
liter of culture, and the sample was centrifuged again for 20 minutes at 9000 rpm. The 
cell paste was re-suspended in twice its weight of lysis buffer (50 mM Tris, pH 7.5 at 
4  °C, 500 mM NaCl, 5 % (v/v) glycerol, 0.1 mM DTT and 0.1 mM PMSF), and cells 
were  disrupted by sonication using one minute bursts until the OD600 decreased to 
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less than 10 % of the original value. The lysate was diluted to 200 mL with lysis 
buffer and cleared of cell debris by centrifugation at 9000 rpm for 40 minutes. After 
adding CaCl2, MgCl2, DNase  I  and RNase,  to 1mM, 2.5 mM and 0.03 mg/mL (both 
enzymes) final concentrations, respectively, the sample was stirred at room 
temperature for two hours. The solution was then heated to 90  °C for 15 minutes 
with stirring, cooled to room temperature, and  the  precipitated contaminating 
proteins were cleared by centrifuging at 9000 rpm for 30 minutes at 4 °C. In order to 
eliminate residual nucleic acid contamination PEI was added to the supernatant at a 
final concentration of 0.2 % (w/v), the sample was stirred  at 4  °C for 15 minutes, 
and  the precipitate  was removed  by centrifugation  at 12000 rpm for 20 minutes. 
Solid ammonium sulfate was slowly stirred into the supernatant to 90 % (w/v) 
saturation, and precipitation was allowed to proceed overnight. The precipitate was 
collected by centrifugation at 12000 rpm for 1.5 hrs, and re-suspended in 30 mL of 50 
mM Tris, pH 7.5 at 4  °C, 5 % (v/v) glycerol. This sample was dialyzed against 2 mM 
potassium phosphate buffer, pH 7.0, 5 % (v/v) glycerol and loaded on a 
hydroxyapatite column (Pall Lifesciences). The flow-through was collected, dialyzed 
against storage buffer (10 mM Tris, pH 7.5 at 4  °C, 200 mM KCl, 5  % (v/v) 
glycerol), and stored in aliquots at  -70  °C. Since the  PhBCCP does not possess 
tryptophan or tyrosine residues, the stock concentration was determined by 
comparing the density of the bands from dilutions electrophoresed on a 20 % 
acrylamide-SDS-tricine gel against bands with known amounts of PhBCCP (71). 
Lanes with known amounts of PhBCCP were obtained by loading dilutions of a 
PhBCCP desalted „standard‟ solution, the concentration of which had been 
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determined in triplicate by quantitative amino acid analysis at the protein facility of 
the Iowa State University. Band density quantitation was performed using a 
Molecular Dynamics Laser Scanning Personal Densitometer (GE Healthcare) and 
ImageQuant software. 
The HsBCCP fragment corresponds to C-terminal 67 amino acids of the 
BCCP domain of propionyl-CoA carboxylase. In order to facilitate removal of the 
histidine tag and eliminate any exogenous residues originating from the vector, the 
p67 sequence from a pDEST17 derivative (a generous gift from Dr. Roy Gravel) was 
subcloned into pSUMO-pro (LifeSensors)  (67). A tyrosine residue was added at the 
N-terminus to allow for concentration determination using uv absorption 
spectroscopy. The plasmid encoding the SUMO-HsBCCP fusion was  introduced into 
E. coli strain Rosetta (DE3)  by electroporation, and transformants were selected by 
growth on LB agar containing  34  µg/ml chloramphenicol and 100 µg/ml ampicillin. 
A single colony was transferred to 5 mL of LB media supplemented with antibiotics 
and grown for 8 hrs with shaking at 37 °C. A 1:100 dilution was performed to initiate 
a 50 mL overnight culture and one liter cultures were inoculated with 20 mL of the 
overnight culture, grown at 37  °C, and protein expression was induced at an OD600 
of 0.8 by addition of lactose to 0.5 % (w/v). Following overnight growth at 30 °C, 
cells were harvested by centrifugation at 4500 rpm at 4  °C, re-suspended in a volume 
of lysis buffer corresponding to five times the cell pellet weight, and lysed by 
sonication in HsBCCP lysis buffer (50 mM sodium phosphate buffer, pH 8, 300 mM 
sodium chloride, 10 mM imidazole, 5 % (v/v) glycerol, 3 mM 2-mercaptoethanol, 1 
mM PMSF). The crude lysate was cleared by centrifugation at 9000 rpm for 30 
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minutes at 4 °C, and the supernatant was subjected  to chromatography on 8 mL Ni-
NTA resin (Qiagen) packed in a 1.5 x 10 cm econo-column (BioRad) according to the 
manufacturer‟s instructions.  The eluted protein was dialyzed against 10 mM sodium 
phosphate, pH 8.0, 60 mM NaCl, 5 % (v/v) glycerol, 5 mM 2-mercaptoethanol, and 
digested overnight at room temperature with SUMO-protease-1. In order to remove 
the protease, the his6-SUMO tag and undigested protein, the sample was passed 
through Ni-NTA resin.  The flow through was collected and  dialyzed against 50 mM 
Tris pH 7.5 at 4 °C, 20 mM KCl, 1 mM 2-mercaptoethanol, 5 % (v/v) glycerol. The 
resulting sample was loaded onto a 8 ml DEAE anion exchange (GE Healthcare) 
column and eluted with a linear gradient of 20-400 mM KCl (VT=200 mL) at a flow 
rate of 2 ml/min. The pooled fractions (2 ml each) containing  HsBCCP were 
concentrated and loaded at 0.1 ml/min onto a 150 ml S-100 Sephacryl resin (GE 
Healthcare) packed in a 1.5 x 100 cm econo-column (BioRad) and equilibrated with 
10 mM Tris, pH 7.5 at 4  °C, 0.8 M KCl, 5 mM 2-mercaptoethanol, 5 %  (v/v)  
glycerol. The eluted sample was exchanged into 10 mM Tris-HCl, pH 8 at 4  °C, 200 
mM KCl and 5 % (v/v) glycerol by dialysis and stored at –70 
o
C. The yield was 10 
mg of protein per liter of bacterial culture and the concentration was determined 
spectrophotometrically using an extinction coefficient of 1450 M cm
-1
 at 276 nm 
(64).  
3.3.3 Stopped flow measurements of biotin transfer 
Biotin transfer was measured by monitoring the intrinsic fluorescence increase 
that occurs upon rapid mixing the enzyme.intermediate complex with the substrate 
biotin acceptor protein (28,32). A solution of 1-2 µM ligase was incubated with half 
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its concentration of biotin and 500 µM ATP for 20 minutes to allow for bio-5‟-AMP 
synthesis. In order  to avoid the complication from the large fluorescence change that 
accompanies ATP binding to the enzyme, PhBPL catalyzed reactions were carried 
out using chemically synthesized bio-5‟-AMP  (31).  Reactions catalyzed by the 
human and  E. coli enzyme were carried out in standard reaction buffer, which 
contains 10 mM Tris, pH 7.5 at 20  °C, 200 mM KCl, 2.5 mM MgCl2. In contrast, 
those reactions catalyzed by PhBPL were performed at pH 7.5, 40  °C and a KCl 
concentration of 500 mM. The higher salt concentration and temperature are 
necessary to obtain complete activity of the thermophilic enzyme  (31), a reflection of 
the fact that  P. horikoshii  intracellular salt concentration is about 500 mM, and the 
organism grows optimally at 98 °C  (91).  Each ligase-intermediate complex solution 
was rapidly mixed with varying concentrations of  BCCP using a Kintek SF-2001 
stopped flow instrument equipped with fluorescence detection. The excitation 
wavelength was 295 nm and fluorescence emission was monitored above 340 nm 
using a  cutoff filter (Corion Corp.). At least six traces spanning 10 half-lives were 
collected at each BCCP concentration. The resulting transients were fit to an 
appropriate model (single or double exponential), and the apparent rates were  plotted 
as a  function of BCCP concentration. Further analysis and interpretation were 
performed as described in the Results section.   
3.3.4 Quench flow measurements of biotin incorporation 
Single turnover measurements of enzyme-catalyzed biotin transfer to the 
BCCP fragments was monitored as a function of time using a Kintek QF-3 quench 





H-biotin, and 500 µM ATP that had been incubated for 30 minutes at the 
working temperature to allow for bio-5‟-AMP synthesis. The second syringe 
contained variable concentrations of each BCCP fragment, ranging from 10 to 200 
µM. All samples were prepared in the appropriate working buffer. Equal volumes of 
the two syringe solutions were mixed and the resulting reactions were allowed to age 
for a specific amount of time, after which they  were quenched with a 2 M HCl 
solution.  Free and BCCP incorporated biotin were separated using TCA precipitation  
(50). In reactions containing PhBCCP, 0.02% (w/v) deoxycholate was included, in 
addition to BSA (0.1 mg/mL), to aid in precipitation. The samples were spotted on 
dried Whatman 3MM squares to which 200 µl of 800 µM unlabeled biotin had been 
added after soaking in 10 % TCA. After drying, the papers were washed twice in 
batch mode in 250 ml of ice cold 10 % TCA and once in 100 ml of cold ethanol. The 
radioactivity retained on the filters was quantified in a LS6500 Beckman counter 
using ReadyProtein
+
 (Beckman) scintillation fluid. Background corrections were 
performed with values obtained from control reactions that contained no BCCP.  
Correction for precipitation efficiency (typically above 80 %)  and conversion from 
dpm to “µM biotin” were carried out using the relation between dpm and  µM 
obtained from the precipitation of a reaction incubated for 30 minutes in order to 
allow for quantitative 
3
H incorporation. Each discontinuous transient was fit to a 
single exponential equation and the resulting apparent rates as a  function of BCCP 
concentration were subjected to linear least squares analysis. The slope of the line 





 3.4.1 Oligomeric states of the reacting species in biotin transfer 
 Interpretation of kinetic and binding data requires knowledge of the assembly 
states of all species participating in a reaction. The oligomerization properties of the 
three biotin protein ligases have previously been characterized using sedimentation 
equilibrium. The human ligase is monomeric in both its unliganded and liganded 
forms  (32). By contrast, the Pyrococcus horikoshii ligase is a constitutive dimer (31). 
However, in the dimer the active sites for biotin transfer are available for interaction 
with the acceptor substrate (34). The E. coli enzyme can also form a homo-dimer, 
albeit in a reaction that depends on the intermediate in biotin transfer, bio-5‟-AMP 
(70). Furthermore, the surface utilized for the homo-dimerization is identical to that 
used for hetero-dimerization with the biotin acceptor protein (92). The equilibrium 
dissociation constant governing homo-dimerization reaction in buffer conditions 
identical to those used in the present studies is approximately 10  µM  (70). 
Consequently, in order to avoid any complication from this competing homo-
dimerization reaction, all kinetic measurements in these studies were performed at a 
total enzyme concentration of 0.5 µM.  
The assembly states of the three  acceptor protein substrates employed in these 
studies were also characterized by sedimentation equilibrium. The  EcBCCP has 
previously been shown to be monomeric over a broad concentration range (28). For 
this work, sedimentation equilibrium measurements were performed on  HsBCCP and 
PhBCCP (data not shown). Global analysis of the data obtained at three loading 
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concentrations and two speeds using a single species model yielded molecular 
weights for the proteins consistent with monomers   
3.4.2 Single turnover assays of the second half reaction in biotin transfer 
This work is focused on the interaction of the ligase with the biotin acceptor 
protein in post-translational biotinylation. Since the rate-determining step in the 
overall reaction is intermediate synthesis, steady state measurements provide limited 
information about this protein:protein  interaction.  However, the reaction proceeds 
through a double displacement mechanism that can be halted after formation of the 
kinetically stable  ligase.bio-5‟-AMP  complex (Figure 14). Mixing of the preformed 
complex with BCCP allows monitoring of the second half reaction independent of the 
first.    
3.4.3. Biotin transfer rates to cognate substrates are similar for the three 
Biotin Protein Ligases 
 In these experiments, BPL is pre-incubated with biotin at half of the enzyme 
concentration and excess ATP to allow for bio-5‟-AMP synthesis. The BPL excess 
over biotin ensures that only one turnover of biotin transfer occurs in the stopped-
flow measurement.  Mixing of the pre-formed complex with BCCP  yields a time-
dependent increase in the intrinsic fluorescence (Figure 16A), that has been shown 
through measurements of the spectra of the two species to be consistent with 
conversion of the bio-5‟-AMP-bound enzyme to the free enzyme (28,32).Transients 
acquired upon mixing the ligase-bio-5‟-AMP complex  at each BCCP concentration 
were fit to either a single or double exponential model to obtain apparent rates. For 
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example, the transient shown in Figure 16A, which was obtained by mixing 
HsBCCP-bio-5‟-AMP with 200 µM HsBCCP, contains two well-separated 
exponential phases.  While both the human and E. coli-catalyzed reactions displayed 
this biphasic behavior at higher BCCP concentrations, all  PhBCCP traces were 
monophasic.   
Plots of the faster apparent rate versus biotin accepting substrate concentration 
for all  three cognate ligase.substrate pairs  were linear and showed  no  evidence of 
saturation  (Figure 16B). Consequently, the slope of each line is interpreted as 
reporting on k1, or BCCP  association with the ligase-bio-5‟-AMP complex, in the 
following mechanism: 





The bimolecular association rates for the three BPLs with their cognate 
substrates (Table 4), obtained from linear regression of the  apparent rate versus 
BCCP concentration profiles (Figure 16B),  reveal that all three reactions are 






. However,  
the  human system displays the fastest rate.   
For reactions that exhibited two exponentials, the rate  of the slower phase 
exhibited no dependence on BCCP concentration, which supports its assignment to 
holo-BCCP dissociation from the ligase (28). The rates of HsBPL and EcBPL  
dissociation  from their cognate holoBCCPs are both approximately 0.2 s
-1




Table 4: Biotin transfer rates for cognate ligase-BCCP pairs. 
 
 

















   
HsBPL          3.5   ± 0.3        3.1   ± 0.3 
EcBPL          1.15 ± 0.07        1.05 ± 0.08 
PhBPL          1.50 ± 0.06 
c





 The errors represent the standard deviation of three independent stopped-flow 
experiments. 
b.
 The errors correspond to the standard deviation of results obtained in 
two independent quench flow experiments. 
c.
 Measurements with PhBPL were carried 
out at 40 C, in 10 mM Tris, pH 7.5, 500 mM KCL, 2.5 mM MgCl2.  All other 







Figure 16. Stopped flow measurements of biotin transfer for cognate ligase-BCCP 
pairs. A. Stopped flow fluorescence trace obtained upon 1:1 (vol/vol) mixing 1 µM 
HsBPL, 0.5 µM biotin, 0.5 µM ATP with 200 µM HsBCCP. Data was collected with 
an equal number of points in two time windows in order to better capture the two 
exponential behavior. The solid line represents the best-fit of the data to a double 
exponential model. B. Plots of the dependence of the apparent rate of biotin transfer 
on BCCP concentration: (■) HsBPL-HsBCCP, (♦) PhBPL-PhBCCP, (∙) EcBPL-
EcBCCP. The data points represent the average of the apparent rate measured at each 
BCCP concentration in three independent experiments with standard deviations 
shown as error bars. The solid lines represent the best-fits of the rate versus 
concentration profiles to a linear equation. 
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3.4.4. Product formation is limited by bimolecular association of enzyme with 
substrate 
The stopped flow assay reports on the disappearance of the ligase.bio-5‟-AMP 
complex but provides no information on product accumulation in the second half 
reaction. Consequently, a quench flow assay was developed to quantify the 
production of biotinylated BCCP.   
In the assay the reactants  are prepared similarly to those used in the stopped 
flow experiments, with the exception that the cold biotin is spiked with  tritium-
labeled  biotin. Once sufficient time has elapsed for bio-5‟-AMP synthesis, an aliquot 
of the ligase-intermediate complex solution is rapidly mixed with BCCP. After aging  
for the appropriate time interval, the reaction is quenched by decreasing the pH. This 
low pH also destroys the non-covalent ligase-bio-5‟-AMP complex while leaving the 
covalent amide linkage between biotin and BCCP intact. In contrast to the stopped-
flow assay, the quench-flow assay of biotin transfer is discontinuous. Therefore,  the 
transient  acquired at each BCCP concentration  (Figure 17A)  results  from multiple 
measurements in which reactions prepared  at a given  acceptor protein concentration 
are aged for variable amounts of time prior to quenching. Separation of free biotin 
from biotinylated BCCP is achieved  using a modification of the TCA precipitation  
method  previously used in steady state kinetic measurements performed on  EcBPL 
(50). The TCA precipitates BCCP and holo-BCCP, but not free biotin or bio-5‟-AMP. 
Quantitation of the radioactivity in the acid insoluble material by scintillation 
counting yields information on the amount of biotin incorporated at a specific time, 
and ultimately a transient (Figure 17A). Transients for all cognate enzyme-substrate 
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pairs are  well-described by a single exponential model, further supporting the 
assignment of the slow rate observed in the stopped flow traces with HsBPL and 
EcBPL to the enzyme-product dissociation rate. Plots of the apparent rates obtained 
from the transients versus BCCP concentration are linear and reveal no evidence of 
saturation (Figure 17B). Furthermore, for all three enzymes the rates obtained from 
the slopes of the lines are identical to the bimolecular association rates obtained from 
the stopped flow measurements (Table 4).  Thus, for all cognate pairs, the rate of 
bimolecular association of enzyme with substrate limits accumulation of the 







Figure 17. Quench flow measurements of biotin transfer for cognate ligase-BCCP 
pairs. A. Transient obtained upon mixing in equal parts 1 µM HsBPL, 0.5 µM biotin, 
0.5 µM ATP against 200 µM HsBCCP. The solid line represents the best-fit of the 
data to a single exponential model. B. Plots of apparent rate versus substrate 
concentration for: (□) HsBPL-HsBCCP, (◊) PhBPL-PhBCCP, (○) EcBPL-EcBCCP. 
The data points represent the average of the apparent rate measured at each BCCP 
concentration in two independent experiments with standard deviations shown as 
error bars. The solid lines represent the best-fits of the rate versus concentration 




3.4.5 Measurements of biotin transfer to noncognate acceptor proteins 
indicate substrate specificity 
The specificity of biotin transfer was investigated by performing stopped-flow 
experiments  with each  BPL and non-cognate substrates (Table  5). Like the cognate 
reactions, noncognate biotin transfer yielded linear apparent rate versus substrate 
concentration profiles. The  bimolecular association rates obtained from linear 




 with the 
fastest rate  observed for PhBPL-catalyzed biotin transfer to  HsBCCP, a non-cognate 
substrate.  The only enzyme capable of biotinylating all three BCCP substrates is 
PhBPL. No time-dependent change in the fluorescence signal is observed upon 
mixing either HsBPL or EcBPL with PhBCCP, consistent with the absence of biotin 
transfer. This result was confirmed by MALDI-ToF MS analysis of reactions 












Table 5:  Stopped-flow measurements of biotin transfer rates for cognate and non-




























    
HsBPL          3.5 ± 0.3 
      (0.23 ± 0.02)
b
 
      0.027 ± 0.004 
 
          N.D. 
c
 
EcBPL          3.2 ± 0.2 
      (0.33 ± 0.03)
b
 
     1.15 ± 0.07 
    (0.21 ± 0.02)
b
 
          N.D. 
c
 
PhBPL         4.3 ± 0.5 
d
      0.42 ± 0.03 
d





The errors correspond to the standard deviation of three independent stopped flow 
experiments. 
b.




N.D., Not Detectable. 
d.
 
Measurements with PhBPL were carried out at 40 C, in 10 mM Tris, pH 7.5, 500 
mM KCL, 2.5 mM MgCl2.  All other experiments were performed at 20 C, in 10 
mM Tris, pH 7.5, 200 mM KCL, 2.5 mM MgCl2 
 
 
For all cognate BPL.BCCP pairs the stopped-flow and quench-flow assays of 
biotin transfer from bio-5‟-AMP yield identical results. In order to determine if this is 
true for noncognate reactions, quench flow measurements of PhBPL-catalyzed 
transfer to noncognate substrates were performed.  The PhBPL was chosen for this 
comparison because of its ability to catalyze biotin transfer to all three BCCP 
substrates. Results of quench flow measurements indicate holoBCCP accumulation 
rates identical to the rates of enzyme.intermediate depletion measured by stopped-
flow (Figure 18, Table 6). Thus, even with non-cognate substrates, bimolecular 
enzyme-substrate association limits the rate of biotin transfer from the intermediate to 









Figure  18. Stopped flow and quench-flow measurements of PhBPL-catalyzed biotin 
transfer to cognate and non-cognate substrates. Rate versus concentration profiles 
obtained by stopped-flow for (■) HsBCCP, (♦) PhBCCP, and (∙) EcBCCP and 
quench-flow flow for (□) HsBCCP, (◊) PhBCCP and (○) EcBCCP. The solid lines 
were obtained from linear regression of the data.  
 
 
Table 6: Rates of PhBPL-catalyzed biotin transfer 
 
          Stopped-flow 
a
         Quench-flow 
b 









   
HsBCCP             4.3 ± 0.5           4.2 ± 0.7 
EcBCCP         0.420 ± 0.03         0.4 ± 0.1  
PhBCCP           1.50 ± 0.06
c





  The errors represent the standard deviation of three independent stopped-flow 
experiments. 
b.
  The errors correspond to the standard deviation of results obtained in 
two independent quench flow experiments. 
c.
 Measurements with PhBPL were carried 
out at 40 C, in 10 mM Tris, pH 7.5, 500 mM KCL, 2.5 mM MgCl2. All other 




3.5 Discussion  
 The structural and energetic basis of the specific enzyme-catalyzed post-
translational biotin addition is not known. Previous steady-state measurements with 
HsBPL indicated that the first step, bio-5‟-AMP synthesis, is the rate limiting step in 
the two-step reaction (32). In this work the second half reaction in biotin transfer was 
measured independent of the first using single turnover stopped-flow and quench-
flow assays. The measurements performed on ligases and substrates from three 
different organisms demonstrate that rate of bimolecular association of enzyme with 
substrate limits post-translational biotin addition. Furthermore, measurements on 
noncognate enzyme substrate pairs reveal specificity in post-translational biotin 
addition.  
The stopped-flow measurements of biotin transfer from the bio-5‟-AMP to 
BCCP, which monitors disappearance of the enzyme.intermediate complex, provides 
information about bimolecular association of enzyme with substrate for all 
ligase/BCCP pairs. This conclusion is based on the observed linear dependencies of 
the apparent rates on BCCP concentration. In order to obtain values for the rate of the 
chemistry of biotin transfer, a quench flow assay for the second half reaction, in 
which product holoBCCP formation is monitored, was applied to the three ligase-
BCCP systems. The linear dependencies and resulting bimolecular rate constants 
obtained with this assay are identical those obtained using the stopped-flow assay. 
Therefore, for all three cognate BPL-BCCP pairs the chemistry of biotin transfer from 
the intermediate to acceptor protein is limited by the enzyme-substrate association 
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rate. As indicated by measurements performed using PhBPL and the non-cognate 
BCCP substrates, this is also true for reactions involving non-cognate pairs.  





, values that are well within range of the commonly observed 
association rates for protein-protein interactions  (93). The rates also agree with 
previous measurements of the  EcBPL-EcBCCP interaction performed in the same 
substrate concentration range  (28). In addition, the results obtained with the human 
system are comparable to those  previously obtained  with p67, a biotin acceptor 
substrate that contains  in addition to the HsBCCP sequence  some  “extra” residues 
originating from the vector sequence  (32). However, the measured association rate 
with p67 was  only twofold slower than that measured  for HsBCCP.  
Measurements performed with non-cognate substrates indicate that PhBPL, 
which biotinylates the two non-cognate substrates at rates comparable to the cognate 
reaction, is the least discriminating of the three enzymes. By contrast, neither the 
HsBPL nor EcBPL can transfer biotin to PhBCCP. The human enzyme, which fails to 







, is the most discriminating of the three ligases. Precedent for such slow 





  measured for the binding of the p66 and p51 subunits of HIV reverse 
transcriptase (94).  
 Previous studies provide limited information on the structural features that 
are important for substrate recognition by biotin protein ligases. In the  
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PhBPL.PhBCCP complex structure the interface is characterized by multiple 
hydrogen bonds mediated by backbone residues as well as numerous van der Waals 
contacts. Functional studies of both E. coli BCCP and ligase variants have also been 
performed. Mutational studies on E. coli  BCCP revealed that, in addition to the target 
lysine, a glutamic acid at position 119  is important for recognition (50). In the E. coli 
ligase several surface loops are proposed to function in BCCP recognition. Functional 
studies of  EcBPL variants at amino acids R116, R119, and A147 confirm the 
importance of three of these loop residues for the process (52).  In addition to the 
catalytic domain, the human ligase is characterized by a ~450 amino acid N-terminal 
extension, which has been shown to both influence the association rate with p67 (32) 
and to directly interact the BCCP domain of Acetyl CoA carboxylase II (42). 
Additional studies to elucidate the structural origins of the range of bimolecular 
association rates exhibited by the BPL.BCCP pairs are in progress.  
The control of biotin transfer by enzyme-BCCP association has potential 
biological consequences. First, consider any single organisms such as H. sapiens in 
which there are multiple biotin-dependent carboxylases. In vivo biotin concentrations 
are in the low nanomolar range (80) and, therefore, there is a limited amount of  
BPL.bio-5‟-AMP.  Therefore, the carboxylase that associates most rapidly with the 
enzyme-intermediate complex should acquire the greatest portion of the available 
biotin. The association rate should depend on both the intrinsic bimolecular rate 
constant for a ligase-carboxylase pair and on the carboxylase substrate concentration. 
Thus,  the  relative  intracellular apo-carboxylase concentrations should be an 
important factor in determining biotin distribution in metabolism. The observed 
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collision-controlled reaction is also important for bifunctional ligases such as EcBPL, 
which, in addition to forming the hetero-dimer with BCCP, homo-dimerizes to 
regulate transcription. Since a single surface on the ligase-intermediate complex is 
utilized for the both dimerization reactions (92), the two are mutually exclusive.  
However,  homo-dimerization is governed by an association rate that is much slower 
than  hetero-dimerization (27,29). This gives rise to a competition between hetero- 
and homo- dimerization in which kinetic preference is given to biotin transfer to 
BCCP. Only after the unbiotinylated BCCP pool has been depleted  and metabolic 
demand for biotin is satisfied  does the enzyme-intermediate complex linger 
sufficiently long to allow homo-dimerization and transcription repression.  
This work quantitatively demonstrates specificity of post-translational biotin 
addition to BCCP substrates. This specificity exists in spite of the high degree of 
evolutionary conservation of sequence and structures in both ligases and BCCP 
substrates. In addition, the measurements indicate that the association of ligases with 
biotin acceptor substrate limits the biotinylation reaction rate. Together, the results 
highlight the importance of protein-protein interactions in post-translational 
biotinylation, and provide a mechanism for determining the distribution of biotin in 












Human Holocarboxylase Synthetase (HCS) catalyzes transfer of the vitamin 
biotin to the biotin carboxyl carrier protein (BCCP) domain of five biotin dependent 
carboxylases. The carboxylases comprise acetyl-CoA carboxylases 1 and 2 (ACC1 
and ACC2), pyruvate carboxylase (PC), 3-methylcrotonyl-CoA carboxylase (MCC) 
and propionyl-CoA carboxylase (PCC). The reaction is catalyzed in two steps. First, 
an activated intermediate, bio-5‟-AMP, is synthesized from biotin and ATP. The 
second step involves covalent linkage between the biotin moiety and a specific lysine 
residue on the carboxylase.  
To address whether HCS displays selectivity among the BCCP domains of the 
five carboxylases, the biotin transfer reaction was investigated using single turnover 
stopped-flow and quench-flow assays. HCS catalyzed biotin transfer to minimal 
biotin acceptor BCCP fragments corresponding to the five carboxylases was 
measured. The results demonstrated that biotinylation of the BCCP fragments of the 
mitochondrial carboxylases PCC, PC, and MCC was fast and limited by the 
bimolecular association rate of the enzyme with the BCCP substrates. In contrast, 
biotinylation of the BCCP fragments of ACC1 and ACC2, to which HCS has 
continuous access from the cytoplasm, was slow and displayed a hyperbolic 
dependence on BCCP concentration.  The correlation between HCS accessibility to 
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the biotin acceptor substrate and the rates of biotinylation suggests that mitochondrial 
carboxylase sequences have evolved to produce fast association rates with HCS in 
order to ensure biotinylation of the carboxylases before mitochondrial import.  In 
addition, the results suggest an important role for the ligase specificity in dictating 
biotin distribution among carboxylases. 
 
4.2 Introduction 
Post-translational modifying enzymes must have specificity towards their 
intended targets, but at the same time be promiscuous enough to allow interaction 
with several partners. Biotin attachment is a post-translational modification essential 
for biotin-dependent carboxylase function. In mammalian cells, biotin linkage is 
catalyzed in a stepwise fashion by Human Holocarboxylase Synthetase (HCS): 
 
HCS + biotin + ATP HCS · bio-5'-AMP  + PPi
HCS · bio-5'-AMP  + apo-carboxylase HCS + holo-carboxylase + AMP
 
In the first step an activated intermediate, bio-5‟-AMP, is synthesized from 
biotin and ATP, with the release of pyrophosphate. The second step involves covalent 
attachment of the biotin moiety to a specific lysine residue on the biotin carboxyl 
carrier protein (BCCP) domain of a carboxylase(23). There are at least three HCS 
variants present in mammalian cells, but only two arise from differential splicing of 
the mRNA(38,40,57). The full length variant (FL-HCS) is comprised of 726 amino 
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acids and a shorter isoform corresponds to a protein that is lacking the first 57 amino 
acids (58-HCS).  
In mammalian cells, there are five carboxylases that require post-translational 
biotin addition by HCS(11). Acetyl-CoA carboxylase 1 (ACC1) is a cytosolic enzyme 
that is involved in fatty acid synthesis by catalyzing the conversion of acetyl-CoA to 
malonyl-CoA. Acetyl-CoA carboxylase 2 (ACC2) catalyzes the same reaction as 
ACC1, but is the product of a different gene. It is involved in fatty acid oxidation, and 
localizes to the cytosolic side of the mitochondrial membrane. Propionyl-CoA 
carboxylase (PCC) synthesizes S-methylmalonyl CoA from propionyl-CoA. This 
mitochondrial enzyme is part of the odd fatty acid synthesis pathway, and is also 
involved in isoleucine, threonine, methionine and valine catabolism. Pyruvate 
carboxylase (PC) also localizes to the mitochondrial matrix and carboxylates pyruvate 
to produce oxaloacetate, a reaction necessary for gluconeogenesis. Finally, 
mitochondrial methylcrotonoyl-CoA carboxylase (MCC) converts 3-
methylcrotonoyl-CoA to 3-methylglutaconyl-CoA, a reaction that is part of the 
leucine degradation pathway. 
It has been demonstrated previously that FL-HCS discriminates among BCCP 
substrates from different species(95). In previous experiments, single turnover assays 
that monitored biotin transfer independently of bio-5‟-AMP synthesis were used. This 
was necessary because comparison of steady state parameters for the overall reaction 
with the rate of bio-5‟-AMP synthesis indicated the rate limiting step in the overall 
reaction was synthesis of the intermediate(28,32). HCS biotinylated the BCCP 
domain of PCC, did not biotinylate the BCCP domain from an archeal organism, and 
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it slowly biotinylated that from E. coli(95). However, HCS selectivity of biotin 
transfer to the endogenous, biologically relevant substrates is unknown.  
In order to investigate HCS substrate specificity among mammalian 
carboxylases, a single turnover assays were used to determine the rates of biotin 
transfer by FL- and 58-HCS to the BCCP domains of ACC1, ACC2, PC, PCC and 
MCC (Figure 19A). Biotin transfer rates to the BCCP domains of the mitochondrial 
carboxylases PC, PCC and MCC were faster than transfer to ACC1 and ACC2. In 
addition, the apparent rate vs concentration profiles were strikingly different.  While 
the BCCP fragments of MCC, PC and PCC displayed a linear dependence of the 
apparent rate on substrate concentration, the BCCP fragments of ACC1 and ACC2 
yielded a hyperbolic dependence, suggesting a difference in the identity of the rate 
limiting step for these two substrates. The different behavior correlated with the 
carboxylase localization, since ACC1 and ACC2 are continuously accessible to HCS 
in the cytoplasm, while the remaining carboxylases are transported into the 
mitochondria. A model consistent with these observations is proposed, whereby HCS 
biotinylates PC, PCC and MCC at a faster rate because these enzymes are only 
transiently present in the cytoplasm and they must be post-translationally modified 
before they reach their final destination. In addition, the data suggest a molecular 
mechanism for the establishment of a hierarchy that determines biotin distribution 








Figure 19. Mammalian biotin dependent carboxylases A. The PC BCCP fragments 
used for these studies are shown in the context of the whole biotin dependent 
carboxylase. All the carboxylases display complex assembly states and have multiple 
copies of the BCCP domains.  The figure was generated using MolMol and the 3BG5 
pdb file, which contains coordinates for Staphylococcus aureus PC carboxylase. B. 
ClustalW multiple sequence alignment of the minimal biotin acceptor domains of the 
five mammalian biotin-dependent carboxylases, highlighting residues that are similar 
(gray) or identical (black). The biotin acceptor lysine lies in the conserved MKM 
sequence.  
 
4.3 Experimental procedures 
4.3.1 Chemicals and biochemicals 
 All chemicals used were at least reagent grade. The concentration of the 
biotin stock was prepared by dissolving a carefully weighted amount of d-biotin 
(Sigma) powder in reaction buffer, adjusting the pH to 7.5, and bringing up the final 
desired volume in a volumetric flask. After filtering through 0.22 µm syringe filter 
units (Millipore), 1 ml aliquots were stored at -70 C. In order to avoid problems 
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related to biotin solubility the concentrations of the prepared stocks were always 
lower than 850 µM. The d-Biotin (8,9-
3
H(N)) (PerkinElmer) was aliquoted and stored 
under argon gas in sealed containers at -70 C. The ATP stock was prepared by 
dissolving the ATP powder (sigma) in water and adjusting the pH to 7.5 with sodium 
hydroxide. The stock concentration was determined by UV absorbance using an 




 at 259 nm, and stored in 0.5 ml aliquots at -
70 °C. The concentrations of the enzymes and the biotin acceptor substrates were 
determined from their UV absorption spectra using extinction coefficients calculated 
according to the method of Gill and Von Hippel(64).  
4.3.2 Sequence composition and cloning  
 The SUMO fusion plasmid used to purify the 67 amino-acid long C-terminal 
region of PCC carboxylase was described previously. This minimal biotin acceptor 
fragment corresponds to the 67 amino acids of the BCCP domain described by Leon 
del Rio (residues 662-728), preceded by an additional exogenous N-terminal tyrosine 
introduced to aid in protein concentration determination by UV 
spectroscopy(67,72,96). ClustalW multiple sequence alignment of the PCC BCCP 
minimal acceptor sequence with those of the remaining carboxylases aided in the 
selection of the corresponding regions of MCC, PC, and the ACC2 (Figure 19B). The 
coding regions for PC (residues 1112-1178), MCC (residues 649-715) and ACC2 
(residues 897-962) BCCP fragments were cloned into the SUMOpro vector 
(LifeSensors) to yield constructs with a cleavable N-terminal 6his-SUMO tag. The 
fragment sequences were amplified using taq polymerase (Invitrogen) with PCR 
primers that introduced Eco31I (Fermentas) sites. In addition, in order to facilitate 
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concentration determination the amplification primers for PC BCCP were designed to 
introduce an exogenous tyrosine residue after the SUMO cleavage site. Because the 
SUMO protease does not cleave before a proline residue, an N-terminal glycine was 
introduced at the N-terminus of the MCC BCCP sequence. A pet28 plasmid coding 
for the full length PC carboxylase (Gift from Dr. Lain Tong) was used as the template 
to amplify PC BCCP. The cDNA sequence of the MCCA gene (Origene, Inc.) was 
used to amplify the MCC BCCP fragment. ACC2 BCCP was amplified from a pBSK 
plasmid containing the ACC2 BCCP coding sequence purchased from Epoch Biolabs 
Inc. After restriction enzyme digestion and agarose gel purification of the PCR 
products and the SUMO-pro vector, the fragments were ligated using T4 DNA ligase 
(Roche). The resulting ligation reactions were transformed by electroporation into E. 
coli Top10 cells and successful clones were selected for on LB-ampicillin media. 
Plasmid DNA from an antibiotic resistant clone was isolated and the correct sequence 
was verified by sequencing at the UMBI DNA sequencing facility. 
The coding sequences for ACC2 (residues 891-965) and ACC1 (residues 785-
859) BCCP fragments were cloned into a pet28 vector, introducing an uncleavable C-
terminal hexahistidine tag. The primers used for PCR amplification contained NcoI 
and XhoI sites (NEB, Inc.).  Template DNA plasmids containing the coding 
sequences for the two ACC BCCP domains were purchased from Epoch Biolabs Inc. 
After digestion, purification and ligation of the PCR products and the vector, the 
ligation mixtures were transformed into E. coli Top10 cells and clones were selected 
for on LB-kanamycin plates. Plasmids were extracted using a mini-prep plasmid 
extraction kit (Zymo Research). For ACC1 this plasmid DNA served as the template 
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for replacement of the three cysteine codons with serine codons using the 
QuikChange Multi Site Directed Mutagenesis Kit from Stratagene. In all cases DNA 
sequencing of the complete insert was used to verify the accuracy of each construct. 
4.3.3 Protein expression and purification 
FL-HCS, 58-HCS and the PCC BCCP domain were purified as previously 
described(32,95). ACC2, MCC and PC BCCP domains were also purified by affinity 
chromatography as his6-SUMO fusions. Plasmids were transformed by elecroporation 
into Rosetta BL21DE3, and clones were selected for with 100 ug/ml ampicillin and 
34 ug/ml chlorampenicol.  A single colony was used to inoculate 5 ml of LB media 
supplemented with antibiotics, and the culture was grown overnight at 37 C with 
shaking at 250 rpm. After dilution into 50 mls of media and 8 hrs of growth, the 
culture was used to inoculate 1 L of media with antibiotics. When the OD600 reached 
0.6, the temperature was lowered to 20 C and expression was induced for 18-20 hrs 
by addition of 0.1 % (w/v) lactose. All subsequent steps were carried out at 4 C. 
Cells were harvested by centrifugation at 4500 rpm. The resulting pellet was 
resuspended in 200 ml of lysis buffer (50 mM sodium phosphate, pH 8, 300 mM KCl, 
10 mM imidazole, 5 % (vol/vol) glycerol, 1 mM PMSF, 3 mM 2-mercaptoethanol) 
and cells were pelleted by centrifugation at 6000 rpms. The pellet was resuspended in 
a volume corresponding to five times its weight of lysis buffer and cells were lysed 
by sonication until the OD600 was reduced to 10 % of its original value. The lysate 
was spun at 8000 rpm and the supernatant loaded on 10 ml of Ni-NTA resin (Qiagen) 
equilibrated with lysis buffer. After the column was washed with lysis buffer with 20 
and then 50 mM imidazole until the absorbance returned to baseline after which the 
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protein was eluted with Ni-NTA elution buffer (50 mM sodium phosphate, pH 8, 300 
mM KCl, 250 mM imidazole, 5 % (vol/vol) glycerol). Sumo protease-1, which was 
purified from a plasmid that was a generous gift from Dr. Christopher Lima(66), was 
added at a 1:100 (weight/weight) ratio, and the resulting sample dialyzed overnight 
into SUMO protease digestion buffer (10 mM sodium phosphate, pH 8.0, 60 mM 
NaCl, 5% vol/vol glycerol, 5 mM 2-mercaptoethanol). The SUMO tag and SUMO 
protease were removed by passing the sample through the Ni-NTA column 
equilibrated with lysis buffer. The MCC sample was concentrated down to 5 mls by 
dialysis against a viscous solution of PEG20000 in storage buffer (10 mM Tris, pH 
8.0, 200 mM KCl, 5 % glycerol), and it was loaded at flow-rate of 0.1 mL/min on a 
1.5 x 75 cm column containing 140 mls of Sephacryl S-100 resin equilibrated in 
storage buffer with 1 mM 2-mercaptoethanol for PC and MCC, or 1 mM DTT for 
ACC2. Before loading the PC BCCP sample onto the size exclusion column as 
described for MCC and ACC2, the sample was dialyzed against Q-sepharose starting 
buffer (10 mM Tris, pH 7.5 at 4 C, 30 mM NaCl, 5 % (vol/vol) glycerol, 1 mM 2-
mercaptoethanol) and loaded on a 10 ml of Q-sepharose resin (GE healthcare) in a 1.5 
x 10 ml econo column (BioRad) at 0.5 ml/min. After washing until the absorbance 
returned to baseline, the protein was eluted at a flow rate of 0.5 ml/min with Q-
sepharose elution buffer (10 mM Tris, pH 7.5 at 4 C, 1 M NaCl, 5 % (vol/vol) 
glycerol, 1 mM 2-mercaptoethanol) using a linear NaCl gradient (30 mM to 1.0 M) of 
a total volume of 300 mL.  
The longer ACC1 and ACC2 BCCP fragments were expressed as non-
cleavable C- terminal his6 tag. These fragments are referred to as ACC1-his6 and 
 87 
 
ACC2-his6, and correspond to the ACC2 BCCP described by Lee et al(42). Their 
expression was carried out in Rosetta E. coli cells  using a similar protocol as the one 
described for PC and MCC, with the exception that expression was induced with 1.5 
% (w/vol) lactose and selection was provided by 50 µg/ml kanamycin and 34 µg/ml 
chloramphenicol. After harvesting, washing and resuspending the cells in lysis buffer, 
the samples were loaded on Ni-NTA. The columns were washed with 20 and 50 mM 
imidazole in lysis buffer, and eluted with Ni-NTA elution buffer. The ACC1-his6 
sample was then dialyzed into Q-sepharose staring buffer, loaded on 10 ml of Q resin, 
and eluted with a gradient of Q-sepharose elution buffer as described for PC BCCP. 
The ACC2-his6 sample did not require an ion exchange column. Both samples were 
concentrated down to 5 ml and chromatographed on Sephacryl S-100 columns as 
described above. The BCCP fragment preparations were determined to be more than 
99 % pure, as judged by electrophoresis on 16.5 % polyacrylamide-SDS-tricine gels. 
In addition, all the BCCP preparations were tested using MALDI for lack of 
contamination with biotinylated BCCP, as well as for their ability to be quantitatively 
biotinylated by HCS. Samples were dialyzed into storage buffer and passed through 
0.22 µm syringe filter units (Millipore). After UV spectrophotometric determination 
of their concentrations, the samples were aliquoted in 500 µL and stored at -70 C. 
4.3.4 Sedimentation equilibrium measurements  
The molecular weights of PC, MCC, ACC1-his6 and ACC2-his6 were 
determined by equilibrium analytical ultracentrifugation. Measurements were 
performed in a Optima XL-I analytical ultracentrifuge (Beckman-Coulter) equipped 
with a four hole AnTi-60 rotor. Centrifugation was performed at 20 C with samples 
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that had been extensively dialyzed against reaction buffer (10 mM Tris, pH 7.5 at 20 
C, 200 mM KCl, 2.5 mM MgCl2). The BCCPs that contained cysteine residues were 
dialized against reaction buffer with 0.5 µM TCEP. Approximately 110 µL of sample 
at three different concentrations ranging from 40 to 400 µM were loaded into a cell 
assembled with a 12 mm six channel charcoal filled epon centerpiece. Samples were 
scanned at 276 nm through sapphire windows. Data were collected after a delay 
period of 8 hours at two different speeds (28000 and 32000 rpm) as an average of 5 
scans with a 0.001 cm radial step. In each case a value for the reduced molecular 
weight, , was obtained by subjecting the data to global analysis using single species 
model in WinNonLin, which was converted to molecular weight using the following 
equation:  
 
in which M is the molecular mass,  is the partial specific volume of the 
protein,  is the buffer density,  is the angular velocity, R is the gas constant and T 
is the temperature. The reaction buffer density was 1.017 g/ml. Partial specific 
volumes were calculated based on the protein sequences using the program SednTerp 
(http://www.rasmb.bbri.org), and had values of 0.7375 ml/g for PCC BCCP, 0.7593 
ml/g for PC BCCP, 0.7485 ml/g for MCC BCCP, 0.7274 ml/g for ACC2-his6 and 
0.7311 ml/g for ACC1-his6. 
4.3.5 Stopped flow measurements of biotin transfer 
Biotin transfer was measured using a Kintek SF-2001 instrument as described 
previously(28,32,95). The stopped flow instrument allows monitoring of the time 
dependent increase in intrinsic tryptophan florescence that accompanies the 
 
 






disappearance of the enzyme-intermediate upon biotin transfer. In these experiments, 
one syringe contained a fixed concentration of enzyme-intermediate complex, while 
the second syringe contained varying concentrations of the BCCP substrates. The 
reactions were initiated by rapidly mixing equal volumes of the two solutions. The 
enzyme intermediate complex was pre-formed by incubating 1 µM HCS with 0.5 µM 
biotin and 500 µM ATP in reaction buffer at 20  for 20 minutes, thus allowing bio-
5‟-AMP synthesis to occur. The emitted fluorescence as a function of time was 
monitored using a 340 nm cutoff filter (Corion Corp.) and an excitation wavelength 
of 295 nm. At least 5 transients were collected at each BCCP concentration, and the 
apparent rates were obtained by individually fitting to an appropriate exponential 
model using the software provided with the Kintek instrument. Subsequent linear 
regression or non-linear least squares fitting to the Michaelis-menten equation were 
performed using PRISM 5 (GraphPad, Inc). 
4.3.6 Quenched flow measurements of biotin transfer 
The rate of HCS-catalyzed biotin incorporation into the BCCP fragments was 
monitored using a QF-3 quenched flow instrument as described previously. A single 
turnover of biotin transfer from HCS to BCCP was monitored by quantitating the 
amount of tritium labeled biotin incorporated into the BCCP fragments. Briefly, a 
solution of enzyme-intermediate, HCS
.
bio-5‟-AMP was rapidly mixed with an equal 
volume of a BCCP solution. The enzyme-intermediate complex was pre-formed by 
incubating 1 µM ligase, 0.463 µM biotin, 37 nM 
3
H-biotin, and 500 µM ATP in 
reaction buffer at 20 C for 20 minutes. At each BCCP concentration, the biotin 
transfer reaction was repeatedly initiated and quenched with 2 M HCl, after aging for 
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an increasing amount of time. The reactions involving ACC1-his6, ACC2-his6 and 
ACC2 BCCP fragments were sufficiently slow to allow hand mixing of the enzyme 
and reactants in 280 µL total volume followed by quenching of 24 µL in 180 µL of 2 
M HCL at different times. BSA was added to a final concentration of 0.1 mg/ml, and 
the sample was transferred to dried 3MM Whatman paper squares pre-spotted with 
200 l of 800 M biotin in 10 % TCA. The papers were washed twice in 250 ml of 
cold 10 % TCA and rinsed once with ethanol. After drying, the radioactivity on the 
papers was counted on a LS6500 Beckman counter using 5 ml of ReadyProtein
+
 
(Beckman) scintillation fluid. After background correction, conversion from dpm to 
“µM biotin” was carried out using the relation between dpm and µM obtained from 
the precipitation of a reaction with quantitative 
3
H incorporation. Apparent rates were 
obtained by fitting the transients to a single exponential model. The apparent rates vs 
concentration profiles were fit to either linear regression in the case of PCC, PC and 
MCC, or to non-linear least square regression to the Michaelis-Menten equation in 
the case of ACC1-his6 and ACC2-his6.  
 
4.4 Results 
4.4.1 Design and preparation of BCCP fragments 
In order to investigate selectivity in HCS-catalyzed post-translational biotin 
addition to the five natural carboxylase targets appropriate substrates were first 
obtained in sufficient quantities for detailed kinetic measurements. Human 
carboxylases are large proteins with complex oligomeric structures (Figure 19A). 
Fortunately, it has previously been shown that a 67 amino acid fragment of the BCCP 
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domain of the human propionyl CoA carboxylase contains all the information 
necessary for HCS-catalyzed biotinylation (72) (Figure 19B). Moreover, this 
fragment can be readily overexpressed and purified in large quantity using the SUMO 
fusion protein strategy(95). A similar strategy was used to obtain BCCP fragments of 
the remaining carboxylases. Multiple sequence alignment of the PCC fragment with 
the sequences of the remaining carboxylases was used to identify the corresponding 
biotin acceptor regions of MCC, PC, ACC1 and ACC2. The BCCP domains of PC 
and MCC were successfully purified in quantities larger than 10 mg/L of bacterial 
culture using the strategy employed previously for the PCC fragment. By contrast, the 
ACC2 and ACC1 fragments presented a variety of problems. Yields of the ACC1 
fragment were low (1 mg/L), and the SUMO-ACC1 fragment could not be cleaved, 
even when extended to include 7 additional endogenous residues before the tag.  
Consequently, following the ACC2 BCCP fragment design of Lee et al. (42) , the two 
acceptor domains were produced a his6 fusion proteins. Relative to the MCC, PC and 
PCC acceptor domains, both ACC1 and ACC2 fragments contained 3 additional 
endogenous residues and the non cleavable -LEHHHHHH tag at the C-terminus, and 
6 additional endogenous residues at the N-terminus. In addition, in order to prevent 
aggregation due to nonspecific disulfide bond formation the three cysteine residues of 
ACC1-his6 were replaced by serine.  
4.4.2 Oligomeric states of the BCCP fragments 
Interpretation of the kinetic data was facilitated by determining the oligomeric 
states of all BCCP fragments using equilibrium analytical ultracentrifugation. Three 
different concentrations of each protein were allowed to reach equilibrium at two 
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different speeds. The resulting six scans were globally fit to a single species model to 
obtain values for sigma. The sigma values corresponded to molecular weights that 
were consistent with the monomeric BCCP species at the concentrations relevant to 
our studies (Table 7). The FL-HCS and 58-HCS have previously been determined to 
be monomers in both the unliganded form and when bound to bio-5‟-AMP(32). 
 
Table7. Assembly state of BCCP fragments 
 
BCCP Analytical M.W. Experimental M.W. 
PCC  7033   7200 ± 500 
a, b
 
MCC 7462 7600 ± 700 
b
 
PC 7254   8000 ± 1000 
b
 
ACC1-his6 9234 9400 ± 900 
b
 





 value obtained from Ingaramo and Beckett (95). 
b. 
molecular weights with 67% 
confidence limits obtained from global nonlinear least-squares analysis of equilibrium 
sedimentation data using WinNonLin. 
 
 4.4.3 Biotin transfer assays 
HCS specificity in post-translational biotin addition was measured using 
stopped-flow and quench-flow kinetic assays.  The rate-determining step in the 
overall two-step biotinylation reaction catalyzed by HCS is bio-5‟-AMP synthesis.  
Therefore, information about the selectivity in the second step in which biotin is 
transferred from the adenylate to the acceptor protein is lacking in steady state 
measurements. Two single turnover assays were used to monitor the biotin transfer 
reaction independent of bio-5‟-AMP synthesis(28,32,95). In both assays the enzyme, 
biotin and ATP are pre-incubated to allow for complete bio-5‟-AMP synthesis. Only 
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then is the enzyme-intermediate complex rapidly mixed with BCCP, and the biotin 
transfer reaction progress monitored. Thus, the reaction monitored in these assays is: 
 





The stopped flow assay allows observation of the time dependent increase in 
HCS intrinsic fluorescence that accompanies biotinylation (Figure 20A). Transients 
obtained upon mixing equal volumes of a constant concentration of enzyme-bio-5‟-
AMP with different concentrations of BCCP fit to a single exponential model, except 
in the case of the PCC fragment. For this substrate the stopped flow traces display a 
second slow phase, the rate of which is independent of BCCP concentration and is, 
therefore, interpreted as reporting on product dissociation (k2) . The second assay, 
which employs a quench-flow system, follows the product, bio-BCCP, accumulation 
and is based on the quantitation of the amount of radioactive biotin incorporated into 
BCCP. Each transient is obtained after repeatedly initiating the biotinylation reaction 
by mixing pre-formed enzyme intermediate complex with BCCP, and quenching it at 
different times (Figure 20B). Quenching of the reaction is accomplished by adding 
2M HCl, which both abolishes enzymatic activity and destroys the enzyme-
intermediate complex. After protein precipitation with TCA, the acid insoluble 
radioactivity is quantified to measure biotin incorporation. All transients obtained 





Figure 20: single turnover assays of biotin transfer. A. Stopped flow 
fluorescence (arbitrary units) trace obtained upon 1:1 (vol/vol) mixing of 0.5 µM FL-
HCS.bio-5‟-AMP with 120 µM MCC BCCP.  The solid line represents the best-fit of 
the data to a single exponential model. B. Transient obtained by quantifying the 
amount of 3H-biotin incorporation after mixing equal volumes 0.5 µM FL-HCS.bio-
5‟-AMP and 120 µM MCC BCCP for different times before quenching. The solid 





4.4.4 Biotin transfer to MCC, PC and PCC BCCPs is fast  
Three of the BCCP fragments, including those of PC, MCC, and PCC, 
exhibited similar kinetic behavior in HCS-catalyzed biotin transfer. The dependence 
of the apparent rates of transfer measured by stopped-flow fluorescence as a function 
of BCCP concentration was linear for all (Figure 21A and 21B) with no leveling off 
of the rate at high substrate concentration. For the PCC fragment, which was 
characterized by biphasic transients, the linear dependence was obtained for the faster 
kinetic phase. This same behavior has previously been observed for the same reaction 
catalyzed by the human, an archaeal and a bacterial ligase(28,32,95). The simplest 
interpretation of the linear dependence is that it reports on the bimolecular association 
of the enzyme-bio-5‟-AMP intermediate with the BCCP substrate, with the slope 
providing the bimolecular rate constant, k1. The magnitudes of the bimolecular rate 
constants obtained for the three carboxylase substrates reveals moderate selectivity in 
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the process. The rate constants span a 3.5 fold range and the order of the rates for the 





Figure 21: Dependence of the apparent rate of biotin transfer on BCCP concentration 
measured by stopped flow (filled symbols) and quench flow (open symbols). A. Rate 
versus concentration profiles obtained by stopped-flow for FL-HCS with PCC(●), 
MCC (▲) and PC (■) BCCPs, and those obtained by quench flow for PCC (○), MCC 
() and PC(□) BCCPs. B. Rate versus concentration profiles obtained by stopped-
flow for 58-HCS with PCC(●), MCC (▲) and PC (■) BCCPs, and by quench flow 
for PCC (○), MCC () and PC(□) BCCPs. The data points represent the average of 
the apparent rate measured at each BCCP concentration in three independent 
experiments in the stopped flow, or two independent experiments in the quench flow, 
with standard deviations shown as error bars. The solid lines were obtained from 










Table 8. FL- and 58-HCS biotin transfer rates to PCC, MCC and PC BCCP 
 





















FL-HCS PCC 3.5 ± 0.3
b
 







 MCC 1.9 ± 0.2 1.9 ± 0.2 
 PC 1.00 ± 0.07 1.00 ± 0.05 
    




3.5 ± 0.3 
 MCC 2.03 ± 0.05 1.81 ± 0.07 
 PC 1.2 ±0.1 1.28 ± 0.05 
    
 
a.
 The errors represent the standard deviation of the rates obtained in three 
independent stopped-flow experiments. 
b.
 values from Ingaramo and Beckett. 
c.
 PCC 
BCCP dissociation rate, in s
-1
, obtained from the concentration independent phase. 
d.
 
The errors correspond to the standard deviation of results obtained in two independent 
quench flow experiments. 
 
The results obtained using the quench flow assay were similar to those 
obtained in the stopped flow measurements. Transients were well-described by a 
single exponential model at all the BCCP concentrations. Moreover, the same linear 
dependence of the apparent rates on substrate protein concentration that was observed 
in the stopped flow analysis was also obtained using the quench flow assay (Figure 
21A and 21B). Additionally, for each enzyme-substrate pair the best-fit lines obtained 
from linear regression are nearly superimposable for the two assays. This behavior 
was also previously observed with the human, archaeal and bacterial ligases. The 
linear dependence and similarity of the quench flow and stopped flow results 
indicates that collision between HCS and the mitochondrial BCCPs is rate limiting 
and that the rate of  biotin transfer to these substrates is not affected by the rate of the 
chemistry of biotin attachment to the acceptor lysine residue. Consistent with the 
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stopped flow results, HCS displays selectivity among the three BCCP domains by 
displaying biotin transfer rates that are 3.5 fold different. In addition, the linear 
dependencies of the rates of FL and 58-HCS-catalyzed reactions for any single BCCP 
substrate were similar. 
4.4.5 Biotin transfer to ACC1-his6 and ACC2-his6 displays a different kinetic 
behavior 
The kinetic behavior of the two ACC BCCP fragments in HCS-catalyzed 
biotin transfer is distinct from that observed for the mitochondrial substrates. For 
simplicity the results obtained with the ACC2 fragment are first presented followed 
by those obtained for the ACC1 fragment. Like the PC and MCC fragments, 
transients obtained upon mixing of the enzyme
.
intermediate complex with ACC2- 
his6 BCCPs were well described by a single exponential model. However, at any 
single substrate concentration the measured rate was significantly slower than the 
rates obtained for the mitochondrial BCCP fragments. For example, the apparent rate 
obtained at a final concentration of 80 µM ACC2-his6 is approximately 40 fold slower 
than the apparent rate at the same concentration of PC BCCP, the slowest of the 
mitochondrial substrates. In contrast to the linear behavior exhibited by the 
mitochondrial BCCPs, ACC2-his6 displayed a hyperbolic dependence of the apparent 
biotinylation rate on BCCP concentration (Figure 22A and 22B).  Nonlinear least 
squares analysis of the data using the Michaelis-Menten formalism yielded a KM of 
approximately 65 µM and a kcat of 0.04 s
-1
 (Table 9). The saturable behavior indicates 
that, in contrast to the three BCCP fragment discussed above, the rate-limiting step in 
the second half reaction for the ACC2 substrate is limited by the chemistry of biotin 
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attachment. In turn, bio-5‟-AMP synthesis, which is associated with a rate of 0.1 s
-1
, 
is not the rate limiting step in the overall two-step biotinylation reaction for this 
substrate.  
Measurements of product incorporation into ACC2-his6 BCCP yielded results 
similar to those obtained in the stopped-flow measurements (Figure 22A and 22B, 
table 9). The slow reaction rates observed for this substrate obviated use of the 
quench-flow, and manual mixing and quenching of 
3
H-biotin spiked reactions was 
used to construct the transients, which were all well-described by a single-exponential 
model. The rates obtained from the analysis are, like those obtained using the 
stopped-flow assay, slow. One source of concern associated with the slow measured 
rates of biotin transfer to the ACC2-his6 is the potential influence of the tag on the 
reaction rate. Although the untagged version of the fragment could not be obtained in 
sufficient quantity to determine full rate versus concentration profiles, sufficient 
material was available to compare its kinetic behavior to that of the tagged protein. 
Comparison of the transients obtained at a final concentration of 20 µM ACC2 BCCP 
with the corresponding transients for 20 µM ACC2-his6 showed that FL and 58-HCS 
catalyze the biotin transfer reaction to both BCCP constructs with similarly slow rates 
that are within error identical (data not shown). Furthermore, the results show that 
both tagged and untagged ACC2 BCCPs are similarly slow. Plots of the measured 
rates versus substrate concentration displayed a hyperbolic dependence on ACC2-his6 
concentration and non-linear least squares of the data to the Michaelis-Menten model 
yielded parameters values that agree with those obtained in the stopped flow 




Figure 22: biotin transfer to the BCCP fragments of acetyl-CoA carboxylases. Panels 
A and B: rate vs concentration profiles for FL-HCS (A) or 58-HCS (B) biotin transfer 
to his6-ACC2 obtained by stopped flow (●) and quench flow (○).The data points 
represent the average of the apparent rate measured at each BCCP concentration in 
three independent experiments in the stopped flow, or two independent experiments 
in the quench flow, with standard deviations shown as error bars. The solid lines 
represent the best-fits of the rate versus concentration profiles to the Michaelis-
Menten equation. Panels C and D: Apparent rates for biotin transfer to ACC1-his6 
obtained by stopped flow (♦) or quench flow (◊) with FL-HCS (C) and 58-HCS (D). 
The quench flow data points represent the average of the apparent rate measured at 
each BCCP concentration in two independent experiments, with standard deviations 
shown as error bars. The stopped flow data points for the three higher ACC1-his6 
concentrations are the average of at least 10 traces each, while the data points at the 
lower concentrations represent the average of three independent experiments, with 

















     





















0.037  ± 0.004 
     
58-HCS 70  ± 30
 
 0.038  ± 0.007
 
 90  ± 20 0.058  ± 0.006 
     
 
a.
 The errors represent the standard deviation of the rates obtained in three 
independent stopped-flow experiments, or the propagated 68% confidence interval 
obtained from the individual fits, whichever was larger. 
b.
The errors correspond to the 
standard deviation of results obtained in two independent experiments, or the 




HCS-catalyzed biotin transfer to ACC1-his6 was similar to transfer to ACC2-
his6. Stopped flow traces displayed apparent rates that were very slow compared to 
those measured for the mitochondrial carboxylases (Figure 22C and 22D).  In 
addition, as observed for ACC2-his6, the apparent rates displayed a hyperbolic 
dependence on ACC1-his6 concentration. Non-linear least square regression of the 
apparent rate dependence on BCCP fragment concentration to the Michaelis-Menten 
provided kcat and KM values of (Table 10). The large errors associated with the 
stopped flow derived KM values for ACC1-his6 are likely due the limited 
concentration range over which the measurements could be performed because of the 
fragment‟s low solubility. The 
3
H-incorporation experiments provided KM values 
comparable to those obtained for ACC2-his6 (Table 10), and kcat values that were 
approximately 2-fold larger than those for ACC2-his6. Moreover, this kcat value is 
similar in magnitude to that obtained for bio-5‟-AMP synthesis.  
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0.12 ± 0.04 
(µM) 
 





0.06 ± 0.02 
     
58-HCS 200 ± 90 0.15 ± 0.05 80 ± 30 0.12 ± 0.03 
     
a.
 The errors represent the propagated 68% confidence limits obtained from globally 
fitting the data, which comprised three independent datasets for the three lower 
concentrations, and at least 10 traces for the three largest concentrations. 
b.
The errors 
correspond to the standard deviation of results obtained in two independent 
experiments, or the propagated 68% confidence interval obtained from the individual 
fits, whichever was larger. 
 
4.5 Discussion 
Holocarboxylase synthetase is known to display preference for its cognate 
human biotin acceptor (BCCP) domain over those of other species (95). However, 
prior to these studies it was not known if the enzyme shows any specificity in biotin 
addition to the five endogenous human BCCPs. It was also not known if the HCS N-
terminus affects the interaction with these BCCP fragments. In this work the 
application of two single turnover assays allowed measurements of specificity in 
HCS-catalyzed biotin transfer to the five endogenous human acceptor substrates 
(28,32,95) that revealed a kinetic preference for mitochondrial over cytosolic 
substrates.     
The BCCP fragments of the mitochondrial carboxylases, PC, PCC and MCC, 
displayed similar kinetic properties in biotin transfer.  All exhibited a linear 
dependence of the apparent transfer rate on BCCP concentration when monitored by 
either stopped flow or quench flow. This behavior indicates that transfer to these 
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substrates is limited by the rate of collision of the enzyme-intermediate with BCCP, 
and provides a measure of the bi-molecular association rate constant formation of the 




, was measured for the PC 




, for the PCC fragment. This 3-fold difference 
in transfer supports the notion that HCS shows modest discrimination in biotin 
transfer to the three mitochondrial carboxylases. However, for all substrates the full 
length and the N-terminal truncated enzymes showed identical rates of biotin transfer. 
The properties of ACC1 and ACC2 BCCP fragments in HCS-catalyzed biotin 
transfer are both qualitatively and quantitatively distinct from those of the three 
mitochondrial substrates. Although, like the mitochondrial substrates, transients for 
the cytosolic substrates were well-described by a single exponential model, the 
apparent rates at comparable acceptor protein concentrations were significantly 
slower (approximately 100-fold). The identical rates measured for the untagged and 
tagged versions of the ACC2 substrate indicate that the slow rates cannot be 
attributed to the presence of the his6 tag. Furthermore, in contrast to the linear 
dependence observed for the mitochondrial substrates, the apparent rates of biotin 
transfer to the ACC substrates displayed a hyperbolic dependence on BCCP 
concentration. This saturable behavior and slow biotin transfer rates indicate that the 
rate-limiting step in the second step of biotin transfer to the ACC substrates differs 
from that for the PCC, PC and MCC substrates and corresponds to either the 
chemistry of biotin attachment or the dissociation rate. Additionally, the slow rates 
measured for HCS-catalyzed biotin addition to the ACC substrates indicates that, in 
contrast to the mitochondrial substrates for which bio-5‟-AMP synthesis is rate-
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limiting, it is the second step of biotin transfer from the adenylate to the acceptor 
protein that is rate-limiting in the overall two step biotinylation reaction.  The kcat in 
the second step of the transfer reaction for the ACC2 BCCP fragment is 
approximately 0.04 s
-1
, and that of ACC1 is twice as large.  Comparison of these rates 
to the bio-5‟-AMP synthesis rate of 0.1 s
-1
 indicates that for the ACC substrates the 
overall reaction rate for the two-step biotin transfer reaction is influenced by the 
second step of biotin transfer from the adenylate to the lysine residue on BCCP(32).  
The two-fold larger kcat observed for 58- vs FL-HCS biotinylation of the 
BCCP fragment of ACC2 was the largest difference observed for the two enzyme 
isoforms. This suggests that the N-terminus of HCS affects biotin acceptor substrate 
recognition mainly for ACC2 and perhaps for ACC1 and are consistent with results of 
NMR measurements performed on the ACC2-his6 construct. Lee et al. monitored the 
chemical shift perturbations that occur in ACC2-his6 spectra upon addition of FL-
HCS and the initial 160 amino-acids of HCS (160-HCS)(42). Signals for several 
ACC2-his6 side chains were shown to undergo chemical shift perturbations upon 
addition of either HCS partner, which led to the proposal that the N-terminus might 
be involved in recruitment of the BCCP substrate. In addition, chemical shift 
perturbations on the N-terminal HCS fragment indicated that this domain undergoes 
conformational rearrangements upon binding ACC2-his6. While these NMR studies 
provided valuable structural information, only the ACC2-his6 BCCP has been 
subjected to them. 
The magnitudes of the rates of BCCP biotinylation correlate with the cellular 
localization of the corresponding carboxylases. Biotinylation of the BCCP fragments 
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of PC, PCC and MCC displayed faster apparent rates than those of ACC1 and ACC2. 
While the latter two are present in the cytoplasm, the other carboxylases are 
transported into the mitochondria matrix. It is tempting to speculate that HCS 
biotinylates PC, PCC and MCC enzymes faster because mitochondrial enzymes are 
only transiently present in the cytoplasm and must be biotinylated prior to 
mitochondrial import. Conversely, HCS has continuous access to ACC1 and ACC2, 
so there is no biological pressure to increase the biotinylation reaction speed.  
Previous studies provide some support for a model that rationalizes faster 
biotinylation rates of substrates destined for the mitochondria based on lack of access 
once transported.  First, even though ACC2 is associated with the mitochondria, it 
localizes to the cytosolic side of the mitochondrial membrane (19). Thus, HCS has 
continuous access to ACC2 as well as ACC1 and a fast biotinylation rate would not 
need to evolve.  Second, carboxylases are imported into mitochondria whether 
biotinylated or not (97). If indeed there is no mechanism to prevent unbiotinylated 
carboxylase transport into the mitochondria, then it is even more pressing that 
biotinylation of mitochondrial carboxylases display a fast rate.  
 The above model assumes that HCS localizes to the cytoplasm, with no HCS 
found in the mitochondria. Subcellular localization of HCS has been a matter of 
debate. Its presence in the cytoplasm is well established through fluorescence 
microscopy localization studies and western blots of fractionated cells (44). While no 
mitochondrial localization of HCS was evidenced in microscopy studies of intact 
cells in which the N- and C- terminally GFP tagged enzyme was expressed, western 
blots of mitochondrial fractions were inconclusive and showed a 60 kDa band that is 
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not consistent with the sizes expected for HCS splice variants (40). The identity of 
this band remains to be confirmed, but suggests the presence of a processed form of 
HCS in the mitochondria. In addition, an independent study involving pulse-chase 
35
S 
labeling of PC provided evidence supporting the presence of biotinylating activity in 
the mitochondria(97). The possibility of HCS mitochondrial localization poses a 
problem for our explanation for HCS faster biotin transfer rates to mitochondrial 
carboxylases. However, confirming the presence of biotinylating activity in the 
mitochondria and the identity of the 60 kDa species would reveal new mechanistic 
possibilities, and does not negate the fact that HCS displays specificity among its 
natural biotinylation targets.  
The observed HCS selectivity suggest a mechanism for biotin distribution 
among carboxylases that is controlled kinetically at two levels. First, HCS displays a 
marked distinction between cytosolic and mitochondrial substrates, favoring biotin 
transfer to those carboxylases to which it has only transient access. Second, HCS will 
display selectivity among the mitochondrial carboxylases. The intracellular biotin 
supply is low and, accordingly, the HCS
.
adenylate complex is limiting. Kinetically, 
the carboxylase that associates most rapidly with this complex will be favored in 
biotinylation.  However, the significance of the relative intrinsic rates of biotinylation 
can be overridden by altering relative carboxylase concentrations. Carboxylases will 
compete for the biotin, and those that have the fastest kinetics of association, which is 
dependent on substrate concentration and inherent association rate, will be 
preferentially modified.  As a result of these preferences, the cell can establish a 
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hierarchy among the carboxylases that determines metabolic use of biotin based on 























Chapter 5:  Conclusions and future directions 
 
The initial biochemical studies presented yielded valuable insight into the 
mechanism of the biotinylation reaction, allowed for the investigation of HCS 
specificity, and suggested a model for the control of biotin distribution among 
carboxylases. Biochemical characterization of the two HCS isoforms demonstrated 
that both variants are monomers in the unliganded form and when bound to bio-5‟-
AMP. Steady state analysis of the overall reaction, as well as pre-steady state kinetic 
measurements of bio-5‟-AMP synthesis indicated that FL- and 58-HCS synthesize 
bio-5‟-AMP at a rate of 0.1 s
-1
. Single turnover measurements of the biotin transfer 
reaction alone indicated that BCCPs from mitochondrial carboxylases were 
biotinylated much faster than the BCCP fragments of cytosolic carboxylases. In the 
case of the two cytosolic carboxylases the second step, biotin transfer, is the slowest 
step observed, likely becoming the rate limiting step. However, in the biotinylation of 
the three mitochondrial BCCP fragments, the HCS catalyzed reaction is limited by 
the rate of bio-5‟-AMP synthesis.   
Comparison of the results obtained from the single turnover stopped flow with 
those of quench flow measurements of the biotin transfer reaction to the 
mitochondrial minimal biotin acceptor substrates revealed that the rate of biotin 
transfer to mitochondrial carboxylases is limited by the rate of enzyme-BCCP 
association. These results were used to propose a model to explain biotin distribution 
among carboxylase substrates based on HCS specificity and the concentration of 
substrate protein. Inside the cell, HCS binds biotin and converts it to bio-5‟-AMP. 
Since this is the rate limiting step in most cases, an accumulation of enzyme-
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intermediate complex occurs. This holo-enzyme then transfers the biotin moiety to 
the carboxylase with the largest apparent association rate, leading to an effective 
competition among the mitochondrial carboxylases. The apparent association rate 
depends on carboxylase concentration and on the intrinsic association rate, which 
gives the cell a chance to override biotin distribution by controlling carboxylase 
expression.  
The E. coli and an archaeal ligase catalyzed biotin transfer reactions were also 
found to be limited by the rate of enzyme-intermediate complex collision with the 
biotin acceptor substrate, indicating that this mechanistic aspect of the reaction is 
ubiquitous.  In the mammalian system, this behavior highlights the importance of 
protein:protein recognition in determining the fate of biotin among the various 
substrates, and mitochondrial ligases likely have evolved sequences that provide 
faster association rates. In the E.coli system, association rates have an equally central 
role. The bacterial ligase acts like a switch in which the ligase can transfer biotin to 
the carboxylase substrate, or homodimerize to repress transcription of biotin 
biosynthetic genes. Since the two interactions are isoenergetic, it is the competition of 
the association rates that controls the switch. 
This work has laid the foundation for several future studies. The structural 
basis of HCS specificity is still vague, and it remains to be determined which residues 
play critical roles in modulating the recognition both on HCS and on the biotin 
acceptor substrate. This is due, in part, to the lack of an X-ray crystallography model 
of HCS. Identifying which residues cause the dramatic difference between the BCCP 
domains of ACC1 and 2 vs those of PC, PCC, and MCC, can potentially provide 
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insight on the involvement of those residues in catalysis vs binding. The effect of 
mutating residues that affect binding will have larger effects on the apparent rate vs 
BCCP concentration profiles for the mitochondrial carboxylases, while those residues 
that affect catalysis might have larger effects on the cytosolic carboxylases. This 
work would require a combination of mutational and crystallographic studies of 
enzyme substrate complex. The PhBPL/PhBCCP crystallographic structure stands as 
precedent for this type of work, although the human complex might prove more 
difficult to crystallize. 
The previous mutational studies can then be expanded to include those 
naturally occurring variants of HCS and BCCP that are linked to MCD. Most of the 
defects are expected to relate to compromised catalytic activity or biotin affinity. 
However, it would be of interest to characterize those mutations that cause low biotin 
responsiveness, since this phenotype may be caused by an increased KM for biotin 
acceptor substrate. This is important because it would yield information on interacting 
residues, and moreover, it would allow prediction of biotin responsiveness. The 
assays that we developed allow us to assign the defective reaction as either bio-5‟-
AMP synthesis or biotin transfer, and to evaluate HCS response to pharmacological 
doses of biotin.   
Studies with the whole carboxylases would be very relevant to the 
understanding of HCS specificity. Human PC (98) and PCC (99) carboxylases have 
been recombinantly expressed and purified in E. coli , and MCC (100) and ACC1 in 
baculovirus systems. ACC2(101) has also been purified from a baculovirus system, 
but is missing 146 amino-acids (102). The single turnover quenched flow experiment 
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could be easily applied to investigate the effect of the complete carboxylase structure 
on biotin transfer. After this characterization is complete, the model that we proposed 
regarding distribution of biotin based on HCS association rate and the concentration 
of carboxylase could be tested in human cells by careful measurement of the 
carboxylases amounts and their relative biotinylation state as a function of biotin 
concentration. 
The key role that phosphorylation plays in regulation of cellular processes 
renders HCS phosphorylation an issue that should not be overlooked. HCS activity 
could be regulated by this phosphorylation. However, cell biology studies to validate 
the relevance of phosphorylation to HCS regulation are lacking.  It is possible that 
HCS phosphorylation is unrelated to its regulation in, for example, a cell cycle 
dependant manner. It is necessary to determine HCS phosphorylation status as a 
function of biotin concentration before any conclusions can be drawn regarding its 
biological significance. The observation that biotin activates guanylate cyclase 
suggests a mechanism by which a cGMP dependent kinase would phosphorylate 
transcription factors to upregulate gene expression, or maybe, phosphorylate and 
regulate HCS. Identifying HCS possible interaction partners and the players of the 
signaling cascade that leads to biotin regulation of gene expression in mammalian 
cells is a field advancement to look forward to. 
 HCS biochemical characterization is not complete. Thermodynamic 
characterization of small molecule binding is important because it provides assays 
that aid in the design of inhibitors to either target or avoid the human ligase. Rational 
drug design has traditionally used thermodynamics as a guide in binding affinity 
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optimization. Bacterial ligases have been proposed as targets for antibiotics (59), and 
for this purpose, avoiding binding to the human ligase would be desirable.  In 
addition, it has been demonstrated that a variety of cancer cells display upregulation 
of ACC, in line with their high growth rate and higher need for lipogenesis, and that 
ACC is a potential anti-cancer target. Moreover, inhibition of ACC1 has shown, in 
some cases, to be selective for cancer cells (103). Given this information, and the 
importance of ACC for metabolism, the idea of ACC as a plausible anti-cancer drug 
is not so farfetched.  
In conclusion, the biochemical studies presented here provided insight into 
HCS mechanism and specificity. Furthermore, the results led to the development of 
models for HCS function that relate to cellular regulation and are of direct biological 
relevance.  We hope to have provided the framework for future HCS studies and 
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